List of Contract Research Companies in United States - 310

4G Clinical’s suite of innovative RTSM and clinical supply optimization software provides the right-sized support for any phase or trial complexity. At 4G Clinical, all studies are supported by a team of RTSM experts to advise trial teams on the best path forward. Our operations team distinguishes itself through their extensive industry expertise and deep understanding of trial designs and mid-study adjustments. 4G Clinical is committed to helping sponsors and CROs follow the science, wherever it may lead, as quickly and as safely as we can. While we will not discover the next novel compound in the lab, we are doing our part by leveraging our extensive experience and technological innovations to bring speed and agility to clinical trials. As a critical partner throughout clinical development, we can help you seamlessly transition and scale your trials through both protocol and supply complexities to help bring crucial medicines to those who need them, faster. To learn more about how we are tackling the bottlenecks in clinical trials through our innovative solutions, Prancer RTSM® and 4C Supply®, visit us at www.4gclinical.com.

AAT Bioquest®, Inc. (formerly ABD Bioquest, Inc.) develops, manufactures and markets bioanalytical research reagents and kits to life sciences research, diagnostic R&D and drug discovery. We specialize in photometric detections including absorption (color), fluorescence and luminescence technologies. The Company's superior products enable life science researchers to better understand biochemistry, immunology, cell biology and molecular biology. AAT Bioquest offers a rapidly expanding list of enabling products. Besides the standard catalog products, we also offer custom services to meet the distinct needs of each customer. Our current services include custom synthesis of biological detection probes, custom development of biochemical, cell-based and diagnostic assays and custom high throughput screening of drug discovery targets. AAT Bioquest® is committed to constantly meet or exceed its customer’s requirements by providing consistently high quality products and services, and by encouraging continuous improvements in its long-term and daily operations. While we continue to rapidly expand, our core value remains the same: Innovation and Customer Satisfaction. We are committed to being the leading provider of novel biological detection solutions. We promise to extend these values to our customers during the course of our service and to continue to support our customers with new products and services.

Abeomics Inc. is founded by scientists for the scientists. Our immunologists, cell biologists and business professionals have contributed for over 25 years to the growth and success of global companies including BD Biosciences, eBioscience and IMGENEX Corporation. We bring our experiences to develop well-validated and specific antibodies by traditional hybridoma technology and by genetic engineering to produce recombinant mouse and rabbit monoclonal antibodies.

With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world's most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients' team – helping them advance today's ideas into tomorrow's medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.

AbTherx is advancing medicine with revolutionary technologies that accelerate and enable therapeutic antibody discovery. Through an exclusive partnership with Gilead Sciences, AbTherx has released Atlas™ Mice, a suite of novel transgenic technologies designed for unmatched performance and FTO. For over 20 years, AbTherx’s passionate, innovative, and collaborative team has pushed the boundaries of antibody discovery technologies, leading to over 1,000 successful antibody discovery campaigns and 13 marketed therapeutics. AbTherx’s industry-leading team creates transformative solutions to overcome the most demanding challenges in delivering innovative medicines. Committed to making its technologies accessible to all, AbTherx offers flexible partnering models that meet the needs of drug developers of all sizes.

AcceGen Biotech proudly develops innovative technologies for the pharmaceutical, biotech and specialty ingredients markets. We are committed to supplying the best products and services with global manufacturing, development expertise and advanced technologies to enhance the overall quality of life. AcceGen Biotech developed significant expertise in cell and genomic research. We provide a variety of high-quality human/animal cells, cell media/kits, cell-derived molecular biology products, gene-based assay kits, Clones, Fish probes and Sequencing products for research use. AcceGen Biotech offers custom cell line generation, microRNA sponges and microRNA Agomir/Antagomir services to simplify the gene research. The aim is to accelerate scientific discovery related to genetic analysis available to academic researchers as well as commercial enterprises. AcceGen Biotech has permanent facilities in Fairfield (New Jersey). We take care of our customers and their global, regional or local requirements. We welcome potential partners and distributors to explore our business all over the world.

The company providesmolecular biology services includingproduction of antibodies, GPCRs, kinases, nuclear receptors, and many other classes of drug targets and therapeutic proteins

AcelaBio, wholly owned by The Alimentiv Health Trust, was incorporated in 2020 and aims to meet the growing clinical research demand for quality and efficiency in laboratory service. Our state-of-the-art facility, located in San Diego, California, is built on deep expertise in clinical and precision medicine research and our scientific and operational experts are dedicated to delivering reliable, high-quality data.

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise focusing on oral dosage forms for the Pharmaceutical industry. Adare's specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactures more than 45 products sold by customers worldwide.

Adesis Inc. is a premier chemistry solution company backed by expert chemists and partnering with biotech and pharma industries to accelerate their research and manufacturing goals. Through the years, we've retained our original culture anchored in ethics, integrity, values, family, transparency, speed, safety and trust. We are one of the few companies that can turn a difficult whiteboard chemistry concept into a physical product. We specialize in organic and organometallic synthesis and deliver organic chemistry services in three areas: early-stage research, scale-up and development, and specialty manufacturing. Our turnaround times are recognized as among the fastest in the industry – a direct result of minimizing red tape, maximizing lab time and quick, efficient decision-making. When clients say ‘let's begin,' we've already started. The companion to this remarkable speed is our commitment to safety. The Adesis Facility Safety Program is designed to constantly raise the level of awareness of safe work practices. Our vigilance extends to the protection of client patents and intellectual property. Backed by the effective use of systems, security and formalized processes, client confidentiality is always a priority. We pride ourselves on our chemists being respected for their brilliance and enthusiasm to collaborate and adapt. If a client needs to shift, we pivot quickly to provide the necessary facilities and specialist brainpower to address any challenge and keep the project moving. The compounds we develop for clients have found use in life-enhancing oncology, anti-infective, animal treatment, central nervous system, immunotherapy, therapeutic, ophthalmic, biomarkers, skin care, catalysts and other applications. Reliably and safely solving the toughest chemistry problems in partnership with its clients is the core purpose of Adesis. Trusted collaboration with exceptional chemistry teams. In Adesis hands, the science is not complicated.

With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world’s most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients’ team – helping them advance today’s ideas into tomorrow’s medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.

Serving the SynBio materials, foods and pharma industries with comprehensive facilities/equipment service programs, We help customers optimize their processes with the most cost effective systems, services, and processes to keep them running on schedule and in budget. Facilities/Equipment Performance Management Service Contracts Upstream Process Consulting - Bioreactor specification - Sensors, Sampling solutions - Automation - Integration Downstream Process Consulting - Filtration - Chromatography - Separations - Drying Calibration – instruments measuring -Temperature - Pressure - Flow - Mass - Optical - Volumetric - Dimensional NIST traceable "cradle to grave" calibration - Performance - Logging - SOP's - Records management Validation – IOQ generation, execution and reports OEM Post Sale Services Management - Installation - Calibration - Integration - On-site Services - Mail-in or Remote Service Center repairs - Warranty Record and Services Management Laboratory/Plant - automation, integration and maintenance Labor Services - field and contract service Equipment Sales - OEM supporting services in process design and performance service contracts - OEM Services Partners include;; Sonotec Non-invasive Flow Meters, BlueSens offgas Analyzers, APS Corp. Industrial Bioprocess Systems, Chemglass Labware, Hamilton Instruments, SecureCell Laboratory Automation

AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial production, including our proprietary CHEF1TM Expression System for efficient protein production with CHO cells. Our company DNA drives us to provide innovative solutions to partner with our customers in helping them reach their goals and accelerate their projects at our cGMP-compliant facilities in the US, Europe and Japan, as well as to facilitate approval and manage spending during the product lifecycle. We forge exceptionally strong partnerships with our customers and we never lose sight of our commitment to deliver reliable and compliant drug substance. Visit www.agcbio.com to learn more.

Ainnocence is a next-generation biotech company with a fast, self-evolving AI drug design platform. The company's third-generation AI system delivers lightning-fast virtual screening and multi-objective pharmacological profile optimization for small-molecule, antibody, and other complex therapeutic modalities. This platform provides a computational screening capacity of up to 10^10 protein sequences or chemical compounds within hours. The end results are a shortlist of candidates with a very high wet-lab hit rate, and a dramatically reduced discovery time and cost. To learn more, visit ainnocence.com.

Ajinomoto is a global leader in the research, development, manufacture and sale of amino acid-based products for the pharmaceutical, nutraceutical, sports nutrition, health and beauty industries as well as food ingredients and consumer food products.

Alcami is a pharmaceutical CDMO that offers contract development and manufacturing services for the healthcare and biotechnology industries.

Alchem Laboratories is a pharmaceutical company that specializes in custom organic synthesis, cGMP manufacturing, and analytical services.

Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Founded in 1984, All American Pharmaceutical is a leading manufacturer of dietary, food and nutritional supplements. We specialize in producing private label and custom formulations for almost anything from general health and sports nutrition to anti-aging products and food products. All American Pharmaceutical has the capability to produce liquids, capsules, powders and tablets products from concept all the way to finished packaging. We are also the exclusive manufacturer and patent holders of two branded ingredients: Kre-Alkalyn® and Kre-Celezine® Formulating and producing effective, high-quality products is not as simple as mixing a few ingredients together and then dumping them into a bottle. Most people who hire a contract manufacturer don't even realize there are major differences between companies, regardless of price. Before hiring any manufacturer, you need to know what their quality standards and current certifications are, how quickly they can turn your products around and if they even have the capability to pull off your job in the first place. After all, your brand's credibility, integrity and hard-earned image are on the line. All American Pharmaceutical has been developing quality products for the past three decades. Over the years, we've listened to your needs and have responded to offer a variety of production and packaging capabilities. And we do it all in our cGMP certified, state-of-the-art 150,000 square foot facility located in Billings, Montana.

Allay Pharmaceuticals, LLC. has been helping pharmaceutical companies worldwide, bringing products to market - from concept to commercialization, assisting every step of the way.

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers. The company was founded by scientists and other professionals with the goal of advancing discovery and innovation. Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge products at a reasonable cost, and providing excellent customer service in addition to the technical knowledge needed to facilitate their use. Our knowledgeable scientists and technicians are available to answer questions regarding any of our products. Over the past decade, Allele has become a reliable source for a wide variety of Molecular Biology reagents, superior fluorescent proteins, camelid derived nano antibodies (nAb), cellular reprogramming services and reagents, and immundiagnostic kits and various other products and custom services.

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. From academics and biotechs of every size to large pharma, we democratize access to foundational, pre-competitive biologics discovery technologies and services to enable drug discovery across six biologic modalities. When you partner with Alloy, you can: • Access our ever-growing stable of services and cutting-edge technology platforms to help you discover the best therapeutic antibodies against your targets • Unlock the therapeutic potential of T cell receptor (TCR) modalities through our fully integrated Keyway™ TCR Discovery service offering • Reach intracellular disease targets at the nucleic acid level with our novel AntiClastic™ ASO Format, which enhances the drug-like properties of antisense • Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Boston, MA, with labs in Cambridge, U.K.; Basel, CH; San Francisco, CA; and Athens, GA. We reinvest 100% of our revenue into innovation and access to continuously develop new groundbreaking platforms and protocols to make our collaborators more successful.

Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.

Alphalyse has pioneered the use of mass spectrometry analysis since 2002. Our scientists have completed over 5,000 protein characterization analyses, including forced degradation studies and over 400 LC-MS-based residual/host cell protein projects. Currently, we are the only CRO in the World certified to offer LC-MS-based MRM analysis under GMP for release testing. As a specialist contract research organization (CRO), we offer protein analysis services to support biopharmaceutical companies in developing and manufacturing patient-safe products such as mAbs, vaccines, recombinant proteins, and cell & gene therapies. You can count on us to work closely with you on developing well-characterized biologics by challenging and improving analysis methods using top-of-the-line mass spectrometry technology (LC-MS). Our comprehensive reports will allow you to carry out data-driven process development and regulatory documentation under ICH Q6B guidelines. Our services include analytical characterization of biopharmaceuticals, mass spectrometric peptide mapping, host cell protein analysis, and quantifying specific proteins in complex samples.

Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more. Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis. Altogen Labs recently developed an `active bioremediation`​ process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.

Founded in 1996 in Cleveland, OH, Analiza, Inc. is a leading US based provider of high quality, affordable analytical services for physicochemical and ADME properties for early drug discovery markets. Adapting gold standard methods for compatibility with early drug discovery (throughput, sample requirements, turnaround time, and cost), Analiza developed the first automated, miniaturized, shake flask system for LogD in 1999. Since 2005, Analiza has provided over 150,000 solubility measurements, 45,000 LogD measurements and 2,500 pKa measurements. Analiza extends the in-house physchem and ADME profiling capabilities of small and large pharma and biotech alike.

Founded in 2002, ANP Technologies, Inc. is an emerging nanobiotechnology company with a major focus on design, development, and marketing of innovative technologies. ANP Technologies, Inc. is a nanobiotechnology company with cutting-edge technology platforms focused on: • Specialty CRO for biological drug R&D • Biodefense and homeland security • Home/point-of-care diagnostic systems • Nanoencapsulation and targeted drug delivery and therapy

At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.

Antigen Discovery, Inc. (formerly ImmPORT Therapeutics, Inc.) provides research services and products specializing in high throughput protein microarray technology that simplifies proteomic biomarker discovery and enables serological and immune profiling of whole proteomes.

Antigen Targeting & Consulting Service Incorporated (ATCS Inc), a biotech company formed in 2009, is dedicated in providing top-quality custom services for the development of vaccines and immunotherapies. The company specializes in targeting antigens to cell surface molecules on dendritic cells for vaccine development, as well as the development of PSMA-targeted PET imaging agents for improved diagnosis of prostate cancer. ATCS Inc also focuses on the translation of multi-antigen targeted off-the-shelf therapies for various medical conditions.

Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases. ASC is a trailblazing CRO/CDMO committed to building a complete iPSC-Gene Editing platform for the production of iPSC-derived products for gene and cell therapy research and development. With the integration of our unique iPSC approach and IP-based site-specific large cargo insertion technology, TARGATT™, we (1) develop immune-compatible master iPS cell lines and (2) deliver large DNA fragments to pluripotent cells that have proven differentiation capabilities. We stand at the forefront of the iPSC-based therapy revolution delivering research- and GMP-grade iPSC solutions along with various downstream assay services. Current Offerings: • iPSC Cell Line Models: iPSC generation, CRISPR & TARGATT™ genome editing, differentiation • Cell Gene Product CDMO: TARGATT™ iPSC Platform for allogeneic cell therapy products/GMP iPSC reprogramming, cell banking, gene editing, and differentiation • Bioproduction: TARGATT™ CHO cell system for antibody screening and bioproduction/TARGATT™ HEK293 cell system for library/antibody screening • Animal Models: Custom and off-the-shelf CRISPR & TARGATT™ mouse models For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.

Every day, Aptar creates “a-ha moments” for its customers and their consumers and patients by continually bringing innovations to market that convert non-dispensing packaging into breakthrough product-dispensing systems, including those that give people more effective ways to put on their favorite fragrance, kids the opportunity to pour ketchup without making a mess and patients connected technologies that help them more easily adhere to treatment. Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com. All of Aptar's current job openings are found at jobs.aptar.com. Job applicants should be aware of recruiting scams on the Internet and social media platforms. The scammers frequently use a company’s logo and photos or the names of its executives to give the appearance of legitimacy. The fraud targets job seekers and uses false and fraudulent offers of employment with legitimate employers, like Aptar, to steal from the victims. No applicant for employment with Aptar is ever required to pay any money as part of the job application or hiring process. In addition, Aptar’s recruiting staff sends email communications to job applicants from email addresses with the “@aptar.com” domain name only. To read more about recruiting fraud or to report an incident please see Aptar's Recruiting Fraud Statement. https://aptar.com/careers/recruiting-fraud-statement/

ARL Bio Pharma is a contract laboratory that provides analytical and microbiological testing for the pharmaceutical industry. Since 1998, ARL has supported the industry-wide commitment to deliver high-quality drug products by providing guidance and test services for all phases of the product lifecycle following USP, FDA, and ICH guidelines. Whether you are a raw material supplier, equipment manufacturer, pharmaceutical manufacturer, pharmacy, or health-system we provide the testing needed to get your drug products ready for release. ARL's dedicated team oversees the entire process from understanding your goals to providing results and helping interpret the data. ARL Bio Pharma is an FDA registered and audited analytical laboratory and DEA licensed for Schedules I through V. The laboratory is ISO 17025:2017 accredited as applicable to our scope of accreditation. 17025:2017 accreditation independently demonstrates ARL's ability to not only comply with quality requirements, but to competently perform specified tests and activities.

ARVYS Proteins Inc. is a Contract Research Organization (CRO) that Specializes in Custom Protein Services for Drug Discovery and Life Science Research. Our strong integrated expertise in protein biochemistry, working experience with various recombinant expression systems and protein classes, up-to-date knowledge in protein technologies, enable us to become a reliable and resourceful partner for our clients. We help at any stage of a protein project. Our goal is to become your preferred outsourcing choice for Protein Services and we will work hard to earn your business. Maximize Project Success with Our Expert Protein Services! Protein Expression - generation of heterologous recombinant proteins in multiple expression systems. Fermentation & Cell Culture - bacterial, yeast, insect and mammalian biomass production for scale up processes. Protein Purification - homogeneous and well-characterized preparations save time, effort and resources. Protein Characterization - Customized design to address specific protein characterization goals. Functional Assays & Assay Development - Protocols with detection by UV-Vis, fluorescence or luminescence spectroscopy. ELISA Development - from selection of assay components to development of a working protocol. Protein Labeling & Conjugation - development of strategies to maximize functionality of modified proteins. Endotoxin Removal & Testing - expert service in less than 1 week. Antibody Development & Production - from generation of antigen to characterization of antibodies.

Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations

Athena Discovery is a contract research organization (CRO) for biotech and pharmaceutical companies specializing in non GLP drug discovery services with a focus on virology and immunology.

AustarPharma is a pharmaceutical company that specializes in drug delivery technologies.

Research product distributor, Contract Services

Avance Biosciences is a leading CRO providing GLP & GMP-compliant assay development, assay validation, and sample testing services to support biological drug development and manufacturing activities world-wide. We provide customized solutions for cell and gene therapies testing including: ID testing by Sanger and NGS sequencing , next-gen sequencing on/off target assays, preclinical DNA & RNA biodistribution studies, mRNA Drug Product, Drug Substance and raw material testing including ID and...

AvantGen is a biotechnology company dedicated in accelerating antibody-based therapeutics for their scientific partners by using innovative platforms. Based in San Diego, the fun and collaborative team is steadfast in this pursuit.

We provide a vast array of services to the research industry that are beneficial to companies of all sizes, from biotechnology start-ups, virtual R&D groups, to the largest multinational firms. As with all great things, discovery drug development begins with an idea or a simple concept. These potential life altering ideas require funding, regulatory navigation, and a significant amount of infrastructure to go from concept to real world application. For new and growing pharmaceutical companies, this funding is increasingly hard to attain. We strive to extend your operating runway. DRUG RESEARCH SERVICES Our CRO team functions as your partner to compound evaluation. The services we offer are instrumental to drug development and provide the client with insight into drug efficacy and tolerability. We offer an array of disease models including microbial infectious disease, diet-induced obesity, diabetes, patient derived xenografts, arthritis, LPS-induced cytokine production and rare genetic diseases as well as breeding services for genetic disease models. ANIMAL WELFARE AND FACILITIES MANAGEMENT We provide your business infrastructure; we offer affordable housing and husbandry services and the use of laboratory space to perform experiments. We also offer our clients use of our Institutional Animal Care and Use Committee (IACUC) for review of protocols and grant proposal review, as well as many other useful services. By facilitating these services, we allow you to focus on the most important aspect of their research.

Avazyme, Inc. a contract research solution provider, offering field and laboratory testing, product development, and expert consulting services to the agriculture and food industries. Avazyme's comprehensive services include food safety analyses for contaminants, pathogens, allergens, food quality and nutrition analysis, genetic trait testing, product safety, FDA Menu Labeling, pesticide residues, mycotoxin analysis, specialized studies for regulatory submission data packages, and a full spectrum of testing for product safety and product quality related to Industrial Hemp. Avazyme provides fast and reliable answers to ensure product safety and high product quality for consumable food, feed, cosmetics, nutraceutical Avazyme also offers comprehensive laboratory and "​in-brewery"​ services to craft breweries and local hops growers and maltsters. Most recently, Volker and his Avazyme team have been a strong supporter and testing partner for the fast-emerging Industrial Hemp Industry in North Carolina and the entire East Coast

Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biologics and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities. We're a team of brilliant minds, each an expert in their field, united by a shared mission to make a real impact in a novel area of biotechnology. We are a highly experienced, entrepreneurial minded team with an impressive scientific background, that lives and breathes a casual, committed, and positive culture and spirit.

BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory located in Salem, NH. BA provides testing services to Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide including: Analytical Testing and Method Development, Microbiological Testing and Environmental Monitoring Services, Biologics, Stability Testing & ICH-compliant Storage, Impurities Testing, Advanced Therapeutics and Extractables & Leachables Studies.

BASF Corporation is the largest affiliate of BASF SE and the second largest producer and marketer of chemicals and related products in North America. BASF creates chemistry for a sustainable future. They combine economic success with environmental protection and social responsibility.BASF Corporation operates more than 100 production and research and development sites throughout North America and operates Verbund sites in Geismar, Louisiana and Freeport, Texas. At Verbund sites, production plants, energy and material flows, logistics, and site infrastructure are all integrated.

The company providesservices inbioanalytic, molecular and cellbiology, in vitro and in vivo pharmacology.The company's capabilities include assay development and in vitro/in vivo pharmacologystudies forantibodies, small molecules, siRNAs, proteins, and gene therapy products.

Every new drug has challenges to overcome on its journey from discovery to market. With today's more specific targets and more challenging chemical spaces, drug delivery and development often requires an enabling technology. We provide a collaborative R&D approach, specializing in particle engineering, drug delivery, drug development and manufacturing expertise to the pharmaceutical industry. We want to partner with you on your challenging molecule and help bring it to market. How can we help?

BioAgilytix is a biotechnology company that specializes in bioanalysis for the biopharmaceutical and life sciences industries.

BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 28 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ employees and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro-Sundia, please visit our website at www.bioduro-sundia.com

BioFactura develops and commercializes biodefense drugs, novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast™ Biomanufacturing Platform, the optimal choice for bringing these products to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.

BioForm Solutions is a San Diego-based contract research organization providing services for the analysis of probiotics in the supplement, food and beverage, cosmetic, and agriculture markets. BioForm Solutions offers industry leading, cutting edge flow cytometry assays developed exclusively by the BioForm team. These assays offer a broad spectrum of solutions for the analysis of probiotic samples in most formulations and are supported by a dedicated staff having over 20 years experience in flow cytometry. We strive to improve our customer's probiotic-based products, including accurately enumerating the viability of probiotics, determining packaging effects, and shelf life evaluation. We are passionate about providing the highest quality services at an outstanding value, along with superior customer service and technical support.

Biolink LifeSciences is a premier contract research organization offering a comprehensive range of services including synthesis, characterization, formulation development, and analytical services for small to large molecules for nearly all dosage forms. Our strength resides with our highly experienced team in synthetic chemistry, analytical method development & validation and formulation development to solve difficult problems.

BiomeSense is a pioneering life sciences startup focused on harnessing the power of the gut microbiome to revolutionize personalized medicine. With our breakthrough technologies GutLab and MetaBiome, we are setting new standards in microbiome data analysis and interpretation, enabling unprecedented insights to understand & leverage the microbiome for human health.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients' needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova's renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early stage research material generation to Process Development and GMP manufacturing, Bionova's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients.

Biopartners Inc. is a global biosample management company with operational offices in the United States and Eastern Europe. It is based in Los Angeles, California. Biopartners Inc. provides comprehensive solutions to support scientific projects.

BIOQUAL, Inc. is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and has a long history of providing state-of-the-art facilities and trained, experienced research scientists, veterinarians and animal care personnel for clients involved in infectious disease investigations, cancer research, and a wide variety of other in vivo and in vitro studies.

We provide services in genomics, statistics, and information technology. Our services include Bayesian analysis, bioinformatics, biomarker development, biostatistics, data management, data pipelines, data science, epigenomics, genetics, genome-wide association, imputation, microarray analysis, multiomics, next-generation sequencing analysis, pharmacogenomics, polygenic risk scores, predictive modeling, project management, proteomics, reproducibility, software development, statistical computing, statistical genetics, and statistical programming. We also developed the Smokescreen® Genotyping Array, advancing research into addiction and treatment approaches. Our highly-skilled transdisciplinary team of experts, carefully assembled from leading research universities and industry, has been solving our clients' research challenges for almost two decades. Extensive experience with a wide range of cutting-edge methods and technologies means we can help ensure your project's success, and provide high-quality deliverables on time and within budget. Whether you have a critical issue, need help with every aspect of a new project—including coordinating complex projects—or only one part of an ongoing project, we can work with you to develop the optimal solution to meet your goals and objectives. Our team can be an integral part of the collaboration, and provide full-service support for all the stages of your research journey. We follow all U.S. Department of Health & Human Services standards for the security of electronic protected health information (HIPAA-compliant). We believe in reproducible, reusable, transparent, and extensible research, and do everything we can to put those values into practice. We are prepared to use our internal computing environment, cloud-computing environments, or client-provided environments, if preferred.

Biovista is a biotechnology company located in Charlottesville, Virginia, founded in 2005 by CEO Andreas Persidis. The company specializes in AI-driven drug repositioning and development services, aiming to enhance the efficiency of bringing new treatments to market. Biovista offers services that include drug repositioning, which identifies new therapeutic uses for existing drugs, and drug de-risking, which assesses and mitigates potential risks in drug development. The company also conducts disease cohort analysis to better understand specific patient populations and treatment strategies. Biovista develops its own drug repositioning programs across various therapeutic areas, including central nervous system disorders, diabetes and obesity, eye disorders, and oncology. The company employs advanced AI technologies to analyze large datasets, facilitating the discovery of novel applications for existing drugs. Biovista is actively involved in R&D projects, reflecting its commitment to advancing drug discovery through innovative approaches.

We are a one-of-a-kind resource built for the future of life science research​. BocaBio is a hybrid CRO serving the pharmaceutical, biotech, and IVD industries​ ISO-certified Biobanx biospecimen inventory ​ ACRP and CCRA-certified clinical research services​ CLIA-certified and CAP-accredited reference laboratory services We help pharmaceutical and IVD research companies develop tomorrow's therapies Our biobank, CRO, and reference lab services enable: Pharmaceutical companies to develop novel therapeutic drugs. IVD companies to develop innovative diagnostic technologies Biotech companies to conduct critical research.

BOC Sciences provides a wide variety of custom services which range from bulk compounds to specialty species in the pharmaceutical, agrochemical, and biotechnology industries. We are committed to providing our customers with the best products and services at the most competitive prices. Given diverse packing options for most of our chemicals, you are welcome to order the desired compounds in any quantities from a few mg to several kg along with all the relevant technical reports. We sincerely hope that our unremitting pursuits of excellence, success, and professionalism will add immense value to your research and development projects!

BIB is a full service CDMO partner offering cGMP and non-GMP mammalian, microbial, gene therapy and cell therapy services.

BTS Research is a Contract Research Laboratory that delivers cGMP/GLP biological services to clients in the pharmaceutical, biopharmaceutical, biotech, academic research, medical devices and related industries.

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.

CalChem Synthesis is a Contract Research Organization (CRO) serving as an outsourcing partner for the biotech and pharmaceutical companies and research institutions. The company mission is to provide high quality non-GMP chemistry services to the chemical community and to maintain customer satisfaction. Our services are based on the belief that our customers' needs are of the utmost importance and we are committed to meeting those needs. The experience of CalChem's team in synthetic organic chemistry and process research and development ensures that all projects are delivered with highest quality standards and on time. CalChem is located in the heart of "Pharma Corridor" in Torrey Pines, San Diego. Our leadership team has over 45 years of combined experience in different sectors of drug discovery and development in pharma industry. If you are located in Southern California, benefit from our services in your backyard and discuss progress of your projects in face-to-face meetings with our chemists on a weekly basis. For national and international clients, progress reports can easily be discussed by conference or video calls. We would welcome the opportunity to earn your trust and deliver you the best services in the industry. With our experience in pharmaceutical contract research and development, we ensure that your projects will be handled smoothly and in your best interest.

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.

Analytical, Microbiological, Pharmaceutical, OTC, Contract Lab, Consulting for Analytical, FDA Deficiency, Water Testing , High Resolution GC-TOF-MS

Develops decentralized clinical trials software.COVID-19: (01/2021) Supporting AstraZeneca for its late-stage COVID-19 drug test.

We are an ISO 13485:2016 Certified Manufacturer developing innovative media formulations for cell cryopreservation, cell culture, and cell handling in cell therapy, gene therapy, and regenerative medicine. We deliver high-quality products with batch-to-batch consistency and rigorous quality controls from raw materials to final product release. We offer manufacturing services, scientific assistance in media formulation, and optimization of existing formulations to meet your specific needs.

At Castor, we believe in the power of clinical research and the power of technology. And we know that together, these forces can help extend human healthspan. To achieve this reality, we must make patient-centered clinical trials a possibility for everyone, anywhere in the world. That's why we are using technology to capture the world's research data and optimize each activity of a clinical trial. From recruitment to monitoring, our modular clinical trial platform makes it easier to design and deploy trials, enroll and engage patients, collect data and analyze results. Each module can be used individually or in unison with others, providing the ability to customize each solution to fit your needs, and grow at your own pace. That's delightful for patients, effortless for study teams, risk-free for sponsors.

• The Cedars-Sinai Biomanufacturing Center (CBC) is a new 25,000 square feet, state-of-the-art biomanufacturing facility located in West Hollywood, California. • Manufacturing the next generation of cell and gene therapies for human IND-enabling clinical trials. • cGMP cell manufacturing facility housing multiple cleanroom cell production suites and process development laboratories. • Combined expertise in a cGMP-compliant approach to manufacture cells at scale with innovative technologies and equipment. • Transferring laboratory protocols to cGMP, up-scaling of processes and achieving Food and Drug Administration standards to bring innovative cell therapy solutions to researchers and translational scientists. • World-class expertise in stem cell (iPSC) biology, gene editing and bioprocessing. • Supporting California Institute for Regenerative Medicine (CIRMN) programs, CBC is providing a much-needed cell biomanufacturing center in California

Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines.

Cell Line Genetics, Inc,(CLG) is the leading independent provider of multi-species Quality Assurance services and products for the Regenerative Medicine market. Headquartered in Madison, Wisconsin and with offices in New York City, CLG's clients include leading universities and research institutes, as well as biotechnology and pharmaceutical companies. For a complete list of CLG products and services please visit www.clgenetics.com.

CellPort Software's secure, compliant, SaaS-based application suite defines and manages all assay workflows, activities, equipment, materials, personnel, data/calculations and projects used by CROs, CMOs, research institutions, bio-pharma companies and regulatory authorities in assay development and biomanufacturing at all stages of development (R&D, GLP, GMP). The CellPort Cell Culture Suite combines the end-to-end laboratory inventory and process management of a Laboratory Information Management System (LIMS) with the highly repeatable QC and manufacturing focus of an Laboratory Execution System (LES).

CellTrans is pioneering cell therapies for clinical application.

As an AAHRPP-accredited IRB, Salus IRB is committed to upholding the highest standards in human research protection while providing concierge customer service and consultative expertise. Salus works with sponsors and investigators to add value by delivering IRB services in a convenient, reliable, and efficient manner. Salus IRB provides ethical review for all phases of research in a variety of therapeutic areas and study designs in the pharmaceutical, biotech and medical device industries, and for single- and multi-site trials. We also provide ethical review for behavioral and social sciences research including data collection, repository, surveys, outcomes, and registries. With multiple meetings weekly and industry-leading 21 CFR Part 11 compliant technologies, our turnaround time for review is 24-48 hours. Our online submission platform, SafeSync and virtual workspace, Globesync™, allow secure, 24/7 access to your complete IRB study file throughout the process.

Center for Breakthrough Medicines is an innovative cell and gene therapy organization focused on contract development and manufacturing organization located in the heart of “Cellicon Valley.”

At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation of human-centric healthcare, by transforming research, and advancing health together. Uniquely, we combine the experience of specialty laboratories with the global reach of a central lab. We have a worldwide network of 1000 labs, hold data from over 85 million patients across five continents, and have the ability to sequence 1000-plus whole human genomes per week. This unparalleled approach to patient data gives you the opportunity to have one partner for all your test services, with consistent access and support across all clinical trial phases.

Certis Oncology is a life science technology company committed to realizing the promise of precision oncology. Certis was founded in 2016 with a singular purpose: to bring certainty to the fight against cancer. Their science delivers clinically relevant, predictive data and they are located in the heart of San Diego's Life Sciences center, Sorrento Valley.

Certus International is an integrated Contract Research Organization and Imaging Core Lab Service Company offering a full range of clinical trial management, consulting and imaging services. Certus, founded in 1995, is a company whose goal is to be accessible, reliable and transparent for its clients. We do this, in part, by being flexible, maintaining a flat organizational structure, having a real person answer the phone when you call and constantly improving customer service, no matter how good you think it is. We also strive to maintain an excellent working relationship with the FDA. Every clinical trial we partner on is customized per the sponsor's requested needs and our suggestions based on the experience that hundreds of trials and over 28 years have given us.

Ceutical Laboratories provides services to the pharmaceutical, medical device, dietary supplement, veterinary, cosmetic, and food industries. Ceutical Labs provides formulation development, design development, project management, process development, analytical testing (chemistry, microbiology, and physical testing), consulting, training, regulatory submissions (IND, NDA , ANDA, 510K, PMA, etc.), regulatory compliance, ESG submissions, quality system implementation, validation support, FDA management, auditing, IT solutions, and marketing expertise. YOUR SUCCESS is our goal. Analytical testing equipment includes GC, GC/MS, HPLC, HPLC/MS, HPLC/MS/MS, ICP, AAS, XRF, Polarimeter, and much more. Our formation expertise includes Rx, solid dose, topicals, and parenterals. Our laboratory has over 50,000 square feet. Our training facility has over 10,000 square feet. We will meet and exceed your expectations. We seek to help our customers achieve regulatory compliance. Our customers who have fully implemented our quality systems have received very few to no observations. We are routinely inspected by US FDA and Health Canada. Our goal is to remain compliant. We are a third party sampling and testing laboratory for US FDA.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.

ChemBridge Corporation is a global provider of enabling chemistry products and contract research services for small molecule drug discovery and chemical biology research. ChemBridge's extensive portfolio includes over 1.3 million diverse and target-focused screening compounds, 14,000 chemical building blocks, 10,000 synthetic macrocycles, our Hit2Lead.com on-line chemical store, and high-end, research-intensive custom library and synthetic/medicinal chemistry services. ChemBridge's research products and services are supported by an experienced, dedicated and friendly customer service and project management team at our San Diego headquarters and by ChemBridge's 25-year track record of innovation, quality and deliverability.

ChemDiv, a fully Integrated Target-to-Market Contract Research Organization (CRO) headquartered in San Diego, CA USA. ChemDiv provides integrated drug discovery and early clinical development deliverables by extracting added value from potential therapeutic candidates via rapid, streamlined outcomes and effective use of capital. - 25 years experience and 2500 customers worldwide - Premium R&D CRO based in USA with global reach - Seasoned project managers - Extensive Academic partnerships - Flexible business models - Competitive pricing options - Industry's largest ever-greening stock compound inventory - Ongoing investments in novel proprietary chemistry and discovery platforms One of the oldest CROs in the industry, ChemDiv provides Integrated Discovery outSource™ solutions that cover the complete range of disciplines needed to bring new drugs for treatment of CNS, oncology, inflammation, metabolic and infectious diseases from target to candidate and through clinical Proof of Concept to the market. ChemDiv champions collaborative development models with co-investors to rescue under-exploited R&D assets for pharmaceutical and biotech partners. #pharma #biotech #chemistry #screening_Libraries #drug_discovery_services

CiVentiChem is a premier Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience serving the pharmaceutical and specialty chemical industries. We operate two facilities in India, specializing in medicinal chemistry, process chemistry, and the manufacturing of Regulatory Starting Materials (RSMs) and intermediates. Our team’s expertise allows us to support projects at every stage, from early drug discovery to full-scale commercial production. In 2019, we successfully sold our GMP kilo-lab in Cary, North Carolina, to Sterling Pharma, further focusing our efforts on expanding our global manufacturing capabilities. In 2024, we made significant investments to increase our production capacity, enabling us to manage programs ranging from gram-scale synthesis to multi-ton manufacturing. To better serve our U.S. clients, we maintain an office in Cary, North Carolina, which facilitates the seamless shipping and receiving of materials from India. CiVentiChem is committed to delivering simple solutions to complex chemistry challenges across all phases of drug development.

We are excited to announce that Clara Health has been acquired by M&B Sciences, a mission-aligned and strategic partner in the clinical research space. We strongly believe that by merging with M&B, we are able to make a greater difference in how patients experience clinical trials and contribute to breakthrough research.

Clinical Trial Network offers quality medical attention to the Houston area, while gathering data to generate industry-leading clinical research to pharmaceutical, bio-technology sponsors, and leading Contract Research Organizations.

Cloudbyz is focused on building cloud-based products and solutions for life sciences customers, and help them innovate drug development and research to bring therapies faster to market which improve patient health and saves lives. Our innovative digital solutions for Pharmaceuticals, Contract Research Organizations (CRO) and Medical Devices companies helps to digitize research, drug and device development and commercialization. Our suite of products include: 1. Cloudbyz CTMS 2. Cloudbyz CTBM 3. Cloudbyz eTMF 4. Cloudbyz EDC, ePRO & eCOA 5. Patient Recruitment 6. Cloudbyz Safety & PV 7. ClinicalWave.ai (AI based platform for Life sciences organizations) Cloudbyz CTMS, eTMF, EDC, and Safety & Pharmacovigilance are built 100% native on Salesforce cloud platform for sponsors, clinical research organizations (CRO), and Clinical Sites. Cloudbyz Clinical Research Solutions are flexible and scalable to enable to manage and collaboration on clinical trial operations while the intuitive, straightforward design allows rapid deployment with a very intuitive and easy-to-use cloud-based solution. Cloudbyz ITPM offers 360° view and real-time visibility across IT planning, execution, and operations and helps organizations to achieve agility, velocity, innovation, and collaboration across IT and business. Cloudbyz ITPM helps CIO, PMO, and IT leaders to visualize the IT landscape, capability mapping, investment, and operational health in real-time and better align IT initiatives with business.

CalCog is a vertically integrated clinical supply services company that provides sourcing, packaging, labeling, storage, and distribution services for early to late phase global clinical trials. We specialize in supporting complex and blinded clinical trials offering advanced support solutions for cold chain and Schedule I to V drugs. Let our expertise optimize your clinical supply chain.

Collaborations Pharmaceuticals, Inc. works on drug discovery for rare and neglected diseases. We develop and license our AI software as well as provide fee for services for pharmaceutical and consumer product services. To date we have won with collaborators $23.5M in grants since 2016.

Community Clinical Health is a community of mental health professionals dedicated to the compassionate and ethical conduct of clinical trials of investigational pharmaceuticals for person with mental illness.

Comparative Biosciences Inc., a Genesis Drug Discovery and Development (GD3) Company, a premier preclinical contract research organization (CRO) committed, for the last 20 years, to providing expert high-quality contract research services to all sectors of the biomedical community. Extensive experience in the biotechnology and pharmaceutical industries provides our staff with an exceptional track record in preclinical research and drug development capabilities. Our on-site histology laboratory offers routine histopathology, special stains, immunohistochemistry (IHC), plastics, GLP antibody tissue cross reactivity (TCR), and histomorphometry services with quick turn around times. We also have the benefit of having an on site board-certified pathologist for evaluation and reporting of all the histology work done here.

Their mission is to accelerate insights and outcomes for patients through leading real-world data, AI technologies, and scientific expertise in partnership with the leading biomedical innovators, healthcare providers, and medical societies.

Contract blending, filling and packaging solutions • Founded in 1959 in Madrid, IA • cGMP compliant and FDA, EPA & ATF registered and licensed • Filling expertise with liquids, gels, pastes, ointments, salves & creams • Stock and custom formulations available • Approved for export

The company provides contract research services for molecular analysis in addition to clinical trial and bio-marker investigation studies. The company also provides laboratory studies for gene expression analysis, genomics and epigenetics.

CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. With its state-of-the-art, multi-site campus in Clearwater, Florida, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale and across a range of dosage forms.

Courante Oncology is a full-service clinical research provider specializing in oncology product development. We offer a wide range of clinical trial management and support services to the pharmaceutical and medical device industries, including project management, clinical site monitoring, quality assurance, and medical writing servies. We believe the challenges of oncology clinical trials require a research team that is uniquely experienced and trained. Our strength lies in our collective experience and our ability to adapt to and meet our clients' specific research needs.

Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization (“CRDMO”) worldwide in terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production. We mainly provide (i) contract research organization (“CRO”) services, including peptide new chemical entity (“NCE”) discovery synthesis; (ii) contract development and manufacturing organization (“CDMO”) services, including peptide chemistry, manufacturing, and controls (“CMC”) development; and (iii) contract manufacturing organization (“CMO”) services, including peptide NCE and generic drug commercial manufacturing. We have established global operations, with projects covering over 50 countries, including major markets in the United States, China, Japan, Europe, South Korea, and Australia. We also provide customers wit peptide drug development, production, and CMC filing support services that meet regulatory requirements in major markets worldwide. In addition to peptides, we have developed a diverse project pipeline focusing on various types of complex peptide- and oligonucleotide-based new chemical entities (“NCEs”). Our peptide conjugation services seamlessly integrate our peptide and oligonucleotide platforms to produce a wide range peptide conjugates products. The introduction of our PeptiConjuXTM and PeptiNuclide LinkTechTM are dedicated to the development and large-scale manufacturing (i.e., kilogram-scale) of peptide-oligonucleotide conjugates (“POC”), peptide drug conjugates (“PDC”), and radionuclide drug conjugates (“RDC”). As of December 31, 2023, we had successfully synthesized approximately 1,800 molecules through these two platforms.

Creative Diagnostics is a biotechnology company based in Shirley, New York, specializing in diagnostic reagents and contract research services. Established in the early 2000s, the company serves global markets in biopharmaceuticals, diagnostics, and academic research. With a team of 25 to 200 employees, Creative Diagnostics generates an estimated annual revenue of $5 million to $25 million. The company offers a range of products, including research-grade and therapeutic antibodies, viral antigens for vaccine development, customizable ELISA kits, rapid test kits, and specialized reagents for gene therapy and bioanalysis. Creative Diagnostics also provides contract assay development, GMP manufacturing for biologics, and custom antibody development through its proprietary Omni-Hybridoma™ platform. Its technical capabilities support rapid commercialization and are particularly relevant for mRNA vaccine development and therapeutic drug monitoring.

Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. They offer custom peptide synthesis, process development, manufacturing as well as catalog products for customers in industry and research area.

Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing three strategically located R&D centers in New Jersey (USA), Toronto (Canada), and Suzhou (China), we are powered by a skilled team of around 250 professionals. As a leader in both conventional and enabling formulation technologies, including amorphous solid dispersion, we take pride in our cGMP facilities, strictly adhering to the rigorous standards set by the FDA, EMA, and NMPA. Our integrated service encompasses the entire new drug development journey, from developability assessment and solid form screening to pre-formulation, formulation development, and CTM and commercial manufacturing. Introducing our pioneering Mol2Med program, designed to expedite small molecule lead compounds or preclinical candidates into Phase I and beyond, with unparalleled efficiency and precision. This 3-step First-Time-Right approach begins at the lead optimization/PCC stage: Step 1: Developability Assessment to guide API form selection and formulation design. Step 2: Solid form screening/selection and Preformulation. Step 3: Formulation development and CTM manufacturing, including packaging, labeling, and shipping to the clinical site. This innovative approach guarantees a robust API form and a scalable manufacturing process, culminating in a First-Time-Right formulation for Phase I. Streamlining the transition to future clinical studies upon Phase I success, our First-Time-Right approach sets the foundation for optimized drug development and success beyond.

Cube Biotech is a contract research organization of membrane protein scientists offering non-GMP services for many applications. We assist in protein preparation, biophysical target characterization, and structure determination by cryo-EM or assay development. Our USP is a vast synthetic copolymer portfolio, enabling more reliable membrane protein research. Copolymers offer, in contrast to detergents, a broad and native picture of your target. Discover endless customization possibilities with our Protein Services – your project, your way, as easy as building with Lego bricks! Build frameworks that are easily incorporated into your own processes. Choose between FTE-based, fee-for-service-based, and milestone-based models. We are looking for long-term collaborations with industrial and academic partners. Contact us to learn more.

Curavit, the "First All-Virtual CRO", designs and executes decentralized - or "virtual" - clinical trials. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality. Curavit brings together the world's leading researchers, enrolls previously untapped and underserved patient populations, applies machine learning algorithms to health and social engagement information to recruit participants, and leverages leading telehealth, patient data, and medical device technologies. Curavit's central virtual site supports remote monitoring and is always audit ready.

Cureline is a global precision and translational medicine CRO located in California (USA). With more than a hundred validated clinical partners in 20 countries, HBS repository in San Francisco Bay area and excellence in laboratory services, Cureline provides a full spectrum of translational research services: global regulatory affairs, custom protocol HBS biobanking, histopathology & digital pathology, molecular and cellular lab services, small animal studies and cell and gene therapy (ATMP) solutions. Since 2003 Cureline is a global leader in commercial biobanking and biomedical research services with a focus on targeted drug R&D, biomarker research and companion diagnostics development.

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 25 global sites and 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com ************************************************** ⚠️NOTICE: Please Be Aware of False Employment Opportunities ************************************************** Please be aware there has been reported fraudulent activity within our industry regarding false offers being made to applicants and requests for personal information from individuals or organizations posing as company representatives. Any applicant who applies to Curia must submit their application through Curia’s career page at https://careers.curiaglobal.com. Applicants will only receive communication, including offer letters, from a curiaglobal.com email address. Please be aware that recent scams used email addresses that are similar to Curia addresses or use other public domain addresses such as gmail.com, yahoo.com and aol.com. Please confirm the sender’s email address prior to sharing your information.

CuriRx, Inc is a certified minority woman owned company with 13,000 sqft, well equipped facility, established in 2012 and located in the Wilmington, MA. With combined experience of over 150 years, we offer high quality development services, in following areas • Analytical Development and testing services o Development, Qualification and Validation o Non-GMP and GMP testing and Stability studies o Product characterization o Particle Characterization • Drug Product Development services o Pre-Formulation and Formulation Development, Lyophilization Cycle Development o Parenteral (IM, IV, SC, IT), Ocular Nanotechnology We have successfully developed over 100 clinical formulations involving biological compounds. Our experience includes developing clinical formulations in both liquid and lyophilized dosage forms. The scientists at CuriRx have proven track record with successes in developing commercial products like Humira & Synagis (high con mAbs), Blincyto (Bispecific) and Gattex (Peptide) etc. • Bulk Drug Substance Development, CHOZN, CHOK1, HEK293, ExpiCHO, E,coli o Cell Line and Clone development o Transient transfection, creating stable pools. o Cell Culture 1Lbioreactors-50 Liter’s bioreactors & Purification o Process characterization

Cytel is the world's leading data-science CRO, driving advancements in human health through robust analytics and innovative clinical trial software. For nearly four decades, we have set the standard in adaptive trial design, leveraging extensive data insights to inform strategy throughout every phase of drug development and commercialization. Our mission is clear: accelerate drug development, enhance success rates, and deliver better patient outcomes. With a comprehensive suite of services from innovative trial design to end-to-end biometrics and real-world evidence, our specialized, multidisciplinary team ensures optimal strategies for preclinical research, trial execution, market access, and reimbursement. Headquartered in Cambridge, Massachusetts, Cytel has a global presence with over 2,000 employees across North America, Europe, and Asia. Learn more about how Cytel is harnessing the power of data to advance human health at www.cytel.com.

At Dash Bio, we're revolutionizing clinical bioanalysis to expedite drug development. By leveraging AI and robotics, we deliver higher-quality assays with turnaround times up to 10x faster than the industry average for clinical trials and GLP studies. While AI startups have transformed drug discovery, the development phase remains bogged down by manual, labor-intensive processes. We're changing that narrative. Our tech-first products automate critical steps, reducing costs and time to market without compromising on quality. Our initial product line focuses on clinical bioanalysis—the testing of samples from clinical trial subjects. With a fresh perspective, we've built a modern platform where quality, automation, and regulation work seamlessly together. Why settle for traditional methods when you can invest in results? We're obsessed with enhancing customer experience and outcomes, constantly pushing boundaries to make processes better and faster.

DHMRI is a 501(c)(3) non-profit, contract research organization specializing in the provision of cutting-edge genomic and metabolomic research services and instrumentation essential to furthering scientific understanding in areas including human health, nutrition, immuno-oncology, plant and animal trait development, and microbiome studies.The organization leverages its expertise and world-leading facilities through scientific collaborations with researchers and other non-profit organizations, world-wide, to deliver advancements in theknowledge and understanding of human wellness, health and longevity.As part of its mandate, DHMRI also provides an integrated core laboratory serving the North Carolina Research Campus (NCRC) and North Carolina university researchers, with cutting edge technologies, and services.

DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary for drug discovery, pre-clinical and IND enabling studies. Our services include histology and in vitro pharmacology as well as molecular, cellular, and micro-biology. We are happy to work with our clients to custom tailor experiments according to their research and development goals. Because we understand that drug development is a fast paced and demanding environment, we guarantee that our services are performed accurately. And to ensure a quick turn-around time, each customer is assigned a secured DC3 account to conveniently download data, schedule pickup, and submit inquiries. Our team, who are committed to superior customer service, has extensive experience in the drug development process and the pharmaceutical industry. You can rely on us to deliver quality data.

Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens' AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types.

Denison is a leading provider of turnkey formulation, manufacturing and packaging solutions for the branded OTC, Rx, and Cosmetic markets. Our product dosage forms include liquids, suspensions, creams, lotions, gels, and ointments. Located in Lincoln, Rhode Island, our state-of-the-art manufacturing site offers manufacturing and packaging of short, medium, and large production runs. In addition, our company maintains two sophisticated laboratories capable of providing a full suite of formulation development and analytical services.

A dermatology clinical research company in Austin. Since 1996, more than 10,000 people have participated in 500+ paid clinical studies for acne, rosacea, hair loss, psoriasis, eczema, sunspots, toenail fungus, and more. They also offer studies for healthy participants.

DevPro Biopharma is a Clinical Research and Development Accelerator with the mission to design, develop, and deliver molecules into medicine.

DKP Genomics is a bioinformatics CRO. We provide top-quality computational biology analysis and bioinformatics infrastructure support to biotechnology, pharma, and agricultural companies and to research foundations. With nearly 15 years of experience in both biotech and major pharma, we're well versed in the standard analyses as well as advanced analyses to help identify targets, biomarkers, compound mechanisms, and advance the understanding of biological pathways and systems in multiple areas: microbial systems, diabetes / obesity, frailty, cancer, and neuroscience. More information can be found at http://www.dkpgenomics.com

DNA COMPASS is implementing ‘last mile' bioinformatic solutions which bridge the gap between centers of genomic discovery and community health practices. Bringing to market data analytics and collaboration solutions which support healthcare professionals by extending the reach of data-driven medicine into community practices. WHY: At DNA Compass, we believe linked health data must work harder, faster, and for more patients. It must empower clinicians NOW to accelerate accurate diagnoses, increase treatment success, and deliver better outcomes. BREAST CANCER DEMO http://dnabreast.com

DPT Laboratories CDMO Services is a pharmaceutical contract development and manufacturing organization specializing in semi-solid and liquid dosage forms, with a legacy of excellence dating back 80 years.

DSG, Inc. is a leading global eClinical provider with a fully unified suite of innovative technology solutions and data management services for the global clinical research community. DSG's eClinical software platform provides competitive advantage that is cost-effective with on-time project delivery. DSG solutions have been used in thousands of clinical trials around the globe with our award-winning eCaseLink™ platform and eCaseLink Designer for enterprise licensing. Founded in 1992, the company is proud to be recognized as the first provider of a fully integrated EDC and IRT Randomization and Trial Supply Management system with the SCDM Data Driven Innovation Award. For more information, please visit www.dsg-us.com

Ecoylse, Inc. offers microbiological products in the areas of energy, industrial, municipal, animal food, and health.The company multiple types of industrial and environmental sample analysis, and contract research. Specialty areas include biocide testing, phage and bacteria isolation, kill studies, species identification, fermentation and growth optimization, fermentation parameter testing. The company also offers custom, GMP small-scale fermentation services for the production of phage and bacteria.Ecolyse is developing ecologically safe, non-toxic solutions to the remediation of microbial induced problems in pipes, containers, tanks, pits, reservoirs and more by utilizing bacteriophage, natural bacterial predators.

With an integrated understanding of pharmacology, toxicology and medicine based on education and experience, Eicarte will assist in the decisions which will smooth the transition through the phases of drug discovery and development.

ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, to accelerate the discovery and development of advanced therapeutics.

Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human biology and accelerating the path to drug discovery and development. This commitment to innovation and efficiency underpins our goal to revolutionize regenerative medicine. We are the partner of choice for supplying high-quality, reliable iPSC-derived cells and kits and conducting customized research services. Connect with Elixirgen Scientific today to discover how we can accelerate your research!

Emcure Pharmaceuticals Ltd. (EPL) is an Indian pharmaceutical company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. Established in 1981, EPL is ranked as the 11th largest company in Indian Pharmaceutical Market as per AWACS MAT Feb'24 data.

Emerald Cloud Lab® (ECL®) provides researchers from various disciplines with access to state-of-the-art scientific labs from anywhere on earth, 24 hours a day, 365 days per year. With ECL researchers utilize a single software interface to securely design, run, and analyze experiments, allowing researchers to spend more time designing protocols and analyzing data, and less time on mundane time-intensive activities in the lab. With ECL every researcher utilizing the platform becomes more productive, and more efficient while reducing operational costs and the impact on the environment.

Emery Pharma (EP) (emerypharma.com) is a FDA registered/inspected, DEA licensed, and cGMP/GLP compliant full service contract research laboratory specializing in microbiology & cell-biology testing, medicinal chemistry, analytical chemistry, and bio-analytical services. EP is located in Alameda, CA, at the heart of San Francisco Bay area. We have been supporting clients both locally and globally. We have deep expertise in drug development and support clients from early preclinical all the way to Phase 3 clinical program. Our Bioanalytical Chemistry team utilizes the state of the art LCMS-MS instrument to unravel the targeted compounds in blood, plasma, skin, etc- We provide assistance with R&D method development, validation, method transfer and analytical services. Medicinal Chemistry: Our team has expertise in diverse therapeutic areas covers all aspects of medicinal chemistry, from strategic planning to hit evaluation and validation to lead optimization and pre-clinical development. Analytical Separation Chemistry: Utilizing NMR, LC-MS, HPLC, GC-MS. Microbiology: Spectrum of Antibacterial and Antifungal Activity, Biofilm Profiling, Resistance Profiling, Cytotoxicity Testing, Microscopy Services, Tissue Efficacy Modeling

Ensigna Biosystems is a contract research organization that provides cutting-edge molecular pathology and genomic services to the biopharmaceutical industry. By combining traditional pathology services with genomics, Ensigna Biosystems is able to characterize biological samples based on protein expression, mRNA levels and mutational status, thus enabling the development of targeted therapies and the implementation of personalized medicine.

Experimental Pathology Laboratories, Inc. (EPL®) is recognized internationally for its ability to meet the needs of the scientific community and the challenges of preclinical safety testing with high quality, on-time histopathology services. EPL’s wholly owned subsidiary, Aclairo, has seamlessly integrated their efforts with our core histopathology services to provide expert toxicological, pharmacological, DMPK and clinical pharmacology support. Together, we are Experienced Proven Leaders.

Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management, make us your ideal partner for all of your radiopharmaceutical development, manufacturing, and commercialization needs.

EXONBIO is a recombinant antibody and recombinant protein company. SPIN (Single Plasma Cell Interrogation) Technology for rabbit recombinant monoclonal antibody (rrMAb) development.

Small Molecules, Contract Manufacturing

Formurex is a Pharmaceutical Contract Development and Manufacturing Organization (CDMO) with a mission to provide the best services in Preformulation, Formulation Development, Analytical, Stability and GMP Manufacturing. We Strive to distinguish our service by upholding our core values: quality, professionalism, respect, and innovation.

Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries around the world.

Frontier Scientific Solutions (FSS) is a contract service organization (CSO) which supports the life science industry by offering cGMP temperature-controlled storage, distribution, and logistic services. Drug development and commercialization require continuous temperature monitoring and control. Frontier's diverse offerings protect product integrity throughout the pharmaceutical supply chain. FSSs' validated software, cGMP storage and drug distribution facility, industry expertise and stringent quality standards support this objective throughout packaging, storage and distribution.

Genemarkers is a Kalamazoo, Michigan-based contract services laboratory specializing in genomics research and molecular testing services, with a primary focus on consumer products, dermatology, skin-related research and therapeutics.. Founded in 2008 by former professor and neuroscientist Dr. Anna Langerveld, Genemarkers has proven its expertise through collaborations with cosmetic, pharmaceutical, and academic research institutions over the years. Taking pride in providing actionable, high quality data and customer service, Genemarkers' CLIA-certified and CAP-accredited laboratory has the ability to support a wide range of projects throughout discovery and development including advanced cellular models/exposures (e.g., dermal/transdermal, hepatic/extrahepatic, neuronal and bronchial/inhalation) and next generation bioinformatics and computational modeling.

Genesis Drug Discovery and Development (GD3), a member of Genesis Global Group, is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, ​and microbiome.

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 200,000 customers from over 100+ countries and regions worldwide have used GenScript's premier, convenient, and reliable products and services. GenScript has over 6,900 employees globally, with about 10% R&D personnel. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 300 patents and about 900 patent applications. As of December 31, 2023, GenScript's products and services have been cited by 87,745 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.

Gilero offers end-to-end device design, development and contract manufacturing in the medical and pharmaceutical industries. Specializing in the areas of consumable and reusable medical devices, drug delivery, combination products and complex electromechanical systems, Gilero offers a wide range of services to meet your medical or drug delivery device needs.

At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our platform. As such, we seek to ensure that DEI is in our DNA, continuing to grow an inclusive culture and diverse workforce. Let's make biology easier to engineer and join our team.

Prolytix, formerly Haematologic Technologies, has 30+ years of experience in protein chemistry, which ensures our team will identify and solve the challenges of your large molecule product. Our services in research and development, characterization by high-resolution mass spectrometry (HRMS), GxP testing, and custom collection devices assist clients worldwide. Using an agile, consultative approach, we support your product’s development from discovery through GMP release. With our proven CMC and regulatory expertise from IND through BLA to our accessible, attentive, and seasoned team, Prolytix is the go-to partner for protein therapeutic projects from routine to complex. For advanced protein development, go with the pro — Prolytix. To learn more about our expertise, services, and products, visit GoProlytix.com.

HemoGenix® is a contract research service laboratory that specializes in in vitro toxicity testing that even large CROs cannot provide. HemoGenix® has developed many proprietary in vitro testing platforms that have been used by small, medium and half of the top 50 biopharmaceutical companies. Known for attention to detail, high quality service and one-on-one personal and reliable consultation, HemoGenix® provides the expertise to help in predicting toxicity, risk and safety of a drug or other agent. Our portfolio of contract research services is expanding and includes in vitro testing of cells and tissues from GLP or non-GLP pre-clinical animal studies. All of our services are also available through Science Exchange. We look forward to working with you. For assay kits, cell expansion reagents and cell culture media, please visit www.preferred-cell-systems.com, or call (719) 264-6251.

Hera BioLabs is an innovative service, product, and licensing provider leveraging decades of gene engineering advancements to create superior preclinical models and exceptional cell lines. Customers benefit from our proprietary platforms and integrated services, including: - SRG RAT® –the first commercially available highly immunodeficient rat model optimal for human xenograft studies. - Onsite rat and mouse studies in our AAALAC-accredited vivarium and laboratories. - piggyBac® Non-viral DNA Delivery Platform – a trusted system for cell line engineering and transgenesis, validated by 750+ peer-reviewed publications. - Cas-CLOVER™ Site-Specific Gene Editing Platform – a proven alternative to CRISPR/Cas9 that virtually eliminates off-target insertions and deletions. - CHO-GS-/- platform for high-titer, high-productivity biologics development and manufacturing. - Custom model and cell line development using our best-in-class gene editing tools. While flexible licensing options allow you to take our technologies in-house, our experienced team, working out of US-based facilities, is ready to deliver robust, high-quality data to accelerate your discovery and development journey. Ready to advance your research? Learn More at https://www.herabiolabs.com/

HTD Biosystems is a contract research & development organization providing development of injectable products. Founded in 2001, our services focus on the rapid advancement of proteins, antibodies, peptides and biological drug candidates from the bench to the clinic. Our capabilities include: • Formulation & Lyophilization Development • GLP Manufacturing of Tox lots • Biophysical Characterization Our experience includes solutions for developing stable injectables for biologics, high concentration proteins, poorly soluble compounds and controlled release formulations, HTD Biosystem's drug delivery technologies include: • Liposomes • Vaccines • Nanoparticles • Nano Suspensions •Lyophilized Products HTD Biosystem's analytical technologies include: • Characterization of sub-visible particles and aggregates • Solid-state characterization • Protein conformation and stability HTD has over 160 clients globally, ranging from small to large pharmaceutical companies in the North & South America, Europe, Australia & Asia. HTD has successfully completed several pharma quality audits.

ICON works to accelerate the development of live-saving drugs and devices by providing a wide range of consulting, development, and commercialization services.

Welcome to the cutting edge of spatial biology and translational research! We're a specialized Contract Research Organization (CRO) and a CLIA High Complexity-certified, CAP-accredited clinical diagnostic laboratory, dedicated to empowering your scientific pursuits! Our focus lies in the field of spatial biology, spatial phenotyping, tumor micro-environment mapping, multiplex immunofluorescence (mIF), IHC, histology, digital pathology, digital and quantitative PCR (dPCR and qPCR), as well as next-generation sequencing (NGS). We use cutting-edge equipment to provide next-generation tissue pathology services, including high-resolution imaging and comprehensive analysis of tissue samples. Our collaborators include scientific teams across the drug development pipeline. Whether you're trying to identify predictive biomarkers or stratify patients, we can help you study the intricate interplay between cells and their surroundings, unlock insights into disease mechanisms, and uncover novel targets. Our team of experts can provide you with end-to-end support including method development and validation, sample testing, regulatory compliance, and clinical trial logistics.

Imaging Endpoints is a leading oncology-focused imaging contract research organization (iCRO) dedicated to enhancing clinical trial outcomes through advanced medical imaging. With a mission to "Connect Imaging to the Cure," the company operates 8 offices across 6 countries and employs over 40 in-house radiologists and nuclear medicine physicians, including experts in oncology imaging. Their services cover the entire spectrum of oncology trials, from translational research to Phase 3 trials, ensuring regulatory compliance and customized imaging solutions. The company offers comprehensive imaging support, including protocol development, site qualification, image acquisition, and advanced imaging analysis. Their proprietary Imaging Clinical Trial Management System (iCTMS) facilitates real-time data tracking, while the RaDAR program accelerates drug development timelines. Imaging Endpoints collaborates with a range of biopharma companies, supporting pivotal oncology trials that lead to regulatory approvals.

Impact Analytical is a compliance services company that specializes in analytical testing for medical devices, including material composition analysis and contaminant investigation.

Impact Biologicals is a biomedical research company that provides recombinant proteins such as prion proteins (PrP) and alpha-synuclein for RT-QuIC.

ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. As part of our ImQuest SUCCESS platform, we provide expert preclinical research services, including compound screening to define compound efficacy and drug target validation analysis to define the mechanism of action and toxicity of pharmaceutical products. We specialize in the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines for infectious disease and cancer drug development programs. Our preclinical contract research services are comprised of interrelated efficacy-defining components for infectious disease (including microbiology and virology), cancer and women's health with parallel evaluations of in vitro and ex vivo toxicity and the pharmaceutical properties and chemical structure of preclinical candidates to efficiently validate you drug target. We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in the field of virology, microbiology and oncology. As such, we understand that each product and each client is unique and we strive to provide effective solutions.

INCOG BioPharma Services is a CDMO with an unparalleled client-centric approach supporting biopharmaceutical partners' clinical and commercial requirements. The company has built a state-of-the-art facility with 90,000 square feet to support biopharmaceutical companies. INCOG BioPharma Services also added 100 million units of syringe/cartridge capacity and announced a collaboration with Resilience to expedite manufacturing of biological drug substance and drug product.

Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and cost. With a team of experienced professionals and a state-of-the-art facility, we are poised to make a significant impact to research and for our customers.

Provides toxicology services, analysis, bioanalysis, drug metabolism and pharmacokinetics (DMPK), and consulting solutions.

Contract research organization since 2009. High-end R&D and cGLP technical services in specialty drug formulation development. Learn more.

Integrated Analytical Solutions, Inc. (IAS), a Genesis Drug Discovery and Development (GD3) Company, is a contract research organization that provides analytical, bioanalytical and drug metabolism services to the pharmaceutical industry. The company was founded in 2004 to fill an unmet need for expert, economical and timely analytical services. Our laboratory is a state-of-the-art facility located in Berkeley, California within one of the world's most active life science research clusters (San Francisco Bay Area). The company is comprised of two operating divisions: GxP and Research and Discovery (R&D). The separate divisions enable the company to accommodate a wide range of projects and deliver fit-for-purpose methods based on each client's specific stage of development and budget. IAS offers each and every client boutique-level attention while providing cost-effective and timely data. Our track record for outstanding service and our collaborative spirit have resulted in long-lasting relationships with biopharmaceutical groups and academic laboratories around the globe.

Interpace Biosciences develops molecular diagnostic tests under the brand Interpace Diagnostics, and provides clincal trial services under the brand Interpace PharaSolutions.

IPA is a progressive, scientific Contract Research Organization (CRO) recently ranked by one of the pharmaceutical industry's most trusted, independent market research sources with the highest competitive score, for its antibody service portfolio.1 The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, in the science and business of bioplatform-based discovery. We provide highly specialized full-continuum therapeutic antibody discovery, development, and out-licensing services [Talem] —with advanced omics and complex intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before. Our mission is to provide our pharmaceutical customers with a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal — is to improve the specificity of biotherapeutics by unlocking the language of the genome. 1. ROOTS 2022: Antibody Discovery Services and Platforms Market (Industry Trends and Global Forecast, 4th Edition), 2021-2035​; p.118

Irvine Clinical Research is an independent, physician investigator-owned clinic specializing in Phase 2-3 sponsored clinical trials in neurology and psychiatry. We have a demonstrated history of enrolling subjects quickly, producing quality data to Sponsors, and ensuring the highest standard of patient care. Our largest areas of study are in Mild Cognitive Impairment/Early Alzheimer's Disease and Depression therapeutic trials. According to publicly available CMS data, Irvine Clinical Research is the top independent site in Alzheimer's Disease clinical trials in the state of California, as measured by industry research grants.

Nitto Avecia Pharma Services is your single source for high-quality chemistry, manufacturing, and control (CMC) services for the pharma, biotech, and medical device industries. Our comprehensive suite of services streamlines processes to accelerate time-to-market. With more than 30 years’ experience, we have deep scientific expertise across a range of products, with a special focus on oligonucleotides. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.

We develop novel therapeutic and diagnostic agents directed at severe diseases. Our specialty is therapeutic radiopharmaceuticals. IsoTherapeutics has been acquired by Telix Pharmaceuticals.

iuvo BioScience is a contract research organization serving the pharmaceutical and medical device industries. Our services encompass pre-clinical research, clinical research and consulting services. With a focus on safety and biocompatibility, iuvo provides assistance through the full product development life cycle, from research to release, including ISO 10993:2018 testing as well as testing programs and advisory services to support regulatory submissions. We have an AAALAC-accredited vivarium and offer full service, GLP-compliant toxicology testing, as well as microbiology and analytical chemistry testing laboratories. We are certified to ISO 13485:2016 and accredited to ISO 17025:2017 quality system standards. We bring decades of experience supporting healthcare and medtech companies of all sizes from around the world, and we work closely with our customers to deliver exquisite science, reliably and on time. Come to us with a specific test, a full program you need managed, or even a research question you need help answering. We are your Partner Research Organization.

iXpressGenes is a synthetic biology company thatspecializes in protein services and instrumentation, and protein and genetic engineering research. The company has experience withextremozymes, microgravity, and trace fluorescent labeling andaccess to a suite of hyperthermophilic genomes from the deep sea vents of the Atlantic Ridge. Proteins and enzymes from these genomes have special qualities that are useful in engineering and metabolic reactions.

Jeeva Clinical Trials Inc. specializes in decentralized clinical trial solutions, offering a unified SaaS platform that enhances global patient engagement and streamlines trial operations. The company utilizes AI-powered tools and modular technology to support efficient trial management, allowing sponsors and medical centers to conduct studies under a single login. Their services include decentralized and hybrid trial solutions, patient recruitment and retention tools, and comprehensive clinical data management. Jeeva's platform features a next-generation Clinical Trial Management System (CTMS) for real-time oversight and protocol adjustments. The company prioritizes security and compliance, adhering to HIPAA, GDPR, and other regulatory standards. Jeeva has successfully implemented its solutions in oncology trials, achieving significant improvements in patient enrollment and data accuracy. They also support academic research, reducing costs and administrative burdens for campus-based studies. With a focus on scalability and workflow standardization, Jeeva provides a patient-centric approach to modern clinical trials.

J-STAR Research, Inc. is a contract chemistry organization serving as an outsourcing partner for the pharmaceutical and biotechnology industries. J-STAR is a leading provider of services in organic synthesis problem solving, early phase non-GMP and GMP manufacturing and crystallization R&D. While high quality synthetic chemistry and process research services continue to be J-Star’s foundation, the company has steadily added and continues to expand in the areas of QC, GMP and QA, Crystallization R&D, Solid Form and Polymorph Screening, Catalysis Screening + Enabling Technology, Highly Potent Compound Handling (HPAPI), Impurity Isolation and Structural Elucidation by NMR and HR-LC/MS and Preformulation for Drug Product Development. J-Star’s expert team of scientists and professionals coupled with solid industrial experience, a track record of dependability, and over 70,000 SF of well-equipped laboratories across two New Jersey research facilities ensures that all projects are delivered in full, on time and with rigorous quality.

KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. KBI is proud to be a JSR Life Sciences Company.

KCAS Bio is a top-tier contract research organization (CRO) that has 45 years of experience with both large pharma and biotech sponsors, providing comprehensive bioanalytical drug development services from early discovery through registration. We have supported more than 300+ FDA approved drugs on the market, developed 5,000+ proprietary and non-proprietary assays to date, and undergone 18 FDA audits with no major findings. Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve sponsors globally with bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management. With the expertise, capacity and flexibility sponsors require, we can fulfill our purpose, which is: to help accelerate the discovery and development of life-changing drugs smoothly, safely and sustainably.

Kemp Proteins, LLC (formerly Kempbio) is a privately-owned, USA-based contract research and manufacturing organization located in Frederick, MD. Kemp Proteins is a premier provider of customized solutions for protein-related challenges. We are "Protein Problem-Solvers" focused on delivering best-in-class gene-to-protein services that optimize productivity and mitigate risk for innovators across the life sciences. The company has over two decades of experience in production of proteins and antibodies for use in basic research, diagnostics and drug development at the pre-clinical stage. Core expertise consists of gene-to-protein expression in mammalian, insect, and E. coli, hybridoma and stable cell-line development, analytical protein characterization, and Upstream/ Downstream process discovery/ optimization. Kemp Proteins' Process Discovery Services transition early therapeutic discovery programs to the biomanufacturing phase. Our teams identify key developability markers early in the discovery process while keeping scale and safety in mind. We use Process Analytical Tools in the initial discovery phase to identify the Critical Process Parameters required to derive Upstream and Downstream Processes that ensure Critical Quality Attributes are met. Once unit operations are defined for scale, we generate engineering and tox-material suitable for reference and NHP studies. The final processes are captured in Manufacturing Batch Records enabling seamless transitions to GMP facilities. Kemp Proteins has experience expressing and purifying a wide range of proteins from antibodies to multi-protein complexes and virus-like particles. The company operates under an ISO9001- and ISO13485-certified Quality Management System and the animal care and use program is AAALAC-accredited.

Kindeva is a global powerhouse CDMO dedicated to manufacturing more tomorrows. Leveraging more than 100 years of innovation, Kindeva provides unrivaled expertise at every stage of pulmonary, nasal, injectable, intradermal, and transdermal therapy development and manufacturing. Whether providing holistic analytical support or scaling sterile injectable fill-finish operations, every solution is backed by extensive technological capabilities, deep regulatory knowledge, and state-of-the-art facilities across the U.S. and U.K. Kindeva’s proactive, informed solutions minimize risk and maximize confidence from ideation through commercialization, bringing high-quality products to patients in need, faster. For more information about our leading drug-device CDMO, please visit www.kindevadd.com.

Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.

KromaTiD, Inc. provides products and services for mutation detection and disease diagnosis. KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions.

Kymanox (‘ki-mah-noks'), meaning Ideal Knowledge Transfer, advances life science innovation through insightful solutions and collaboration. We do this by accelerating the design and commercialization of modern medicines for our customers using integrated engineering, scientific, compliance, and project management solutions that are insightful, collaborative, and comprehensive. By building and supporting the development of modern medicines, Kymanox has proven, end-to-end solutions that are helping bring better Life Science Products to the market- and keep it there. We do all of this with heart and pride… because patients deserve better. Kymanox, founded in 2004, serves clients from Fortune 100 companies to virtual start-up companies all across the globe. Headquartered in Research Triangle Park, NC, we have US offices in Boston and Philadelphia, and since 2022 have expanded to Germany, Switzerland, and Israel.

"Discover the World of LAMPIRE Biological Laboratories! Are you looking for cutting-edge solutions in the life sciences industry? Look no further! LAMPIRE Biological Laboratories, established in 1977, is a leading provider of top-notch biological products and services. Specialized Offerings: LAMPIRE excels in polyclonal and monoclonal antibody development, and a wide variety of biological products. From secondary antibodies to purified IgGs, human and animal blood products, and an extensive range of animal tissues and organs, we have everything you need for your research and diagnostic needs. Comprehensive Services: Our commitment goes beyond products. Our team of experts provides a range of support services, including peptide synthesis, antigen design, antibody purification, custom conjugation, and immunoassay development. Let us accelerate your research and take it to new heights! Trusted Worldwide: At LAMPIRE, we take pride in earning primary vendor status with biopharmaceutical, diagnostic, and medical device manufacturers worldwide. Our quality and reliability have made us a preferred partner in the industry. Customer-Centric Approach: Your success is our priority. We believe in providing each customer with our best efforts at all times. Our courteous and attentive treatment is a testament to our commitment to your satisfaction. Connect with Us: Ready to explore the world of LAMPIRE Biological Laboratories? Visit our website at www.lampire.com to learn more about our products and services. You can also reach out to us via email at lampire@lampire.com or call us at 215-795-2838 with any inquiries. Join the community of researchers and scientists who trust LAMPIRE for their critical projects. Let's drive innovation together!"

Levena Biopharma is a global ADC CRO/CDMO dedicated to advancing Antibody Drug Conjugate programs from discovery to the clinic and beyond. In 2013, Sorrento acquired Concortis Biosystems, establishing Levena as an independent, wholly-owned subsidiary of Sorrento Therapeutics to offer the scientific community access to our leading-edge linkers, payloads, and site-specific conjugation technologies. Our mission is to collaboratively develop conjugates that maximize the therapeutic potential of our clients' native or engineered antigen-targeting biomolecular carriers (antibodies, proteins and nucleic acids) and advance precision medicine options for patients with unmet clinical needs. We welcome discussing your projects and our capabilities at our world-class facilities in: -- San Diego (R&D Headquarters, 2013) -- Suzhou (CMC and cGMP, 2017) Levena provides small and large scale proof-of-concept (POC) conjugation services as well as complete ADC characterization using advanced analytical tools such as HPLC (HIC, SEC, RP), iCIEF and LC-MS, quality assessment (Drug-to-Antibody Ratio, purity via SDS-PAGE, aggregation, endotoxin, residual drug) and in vitro pharmacology for cytotoxicity studies. Expanding on IP from Concortis starting in 2008, we continue to maintain and grow our comprehensive, in-house portfolio of leading-edge ADC solutions, enabling Levena's world-class chemistry & conjugation teams to efficiently deliver constructs with unsurpassed quality and therapeutic potential. Our proprietary and non-proprietary ADC solutions include Linkers, Payloads, L-P chemistries and site-specific conjugation platforms [C-Lock™, K-Lock™ and C-Lock™/K-Lock™ for dual-drug delivery], enabling efficient development of mechanistically-defined ADCs with exacting, reproducible performance for safety, efficacy and clinical success.

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical industry. We secure and optimize your supply chain with our extensive qualified API partner network, global drug product development and manufacturing facilities, and regulatory and market intelligence services delivering customized solutions that get your products to market faster. Full-service, expert support that accelerates the new product pathway. Now that’s smart. • Established in 2005 • ISO 9001-2015 QMS certified company • CGMP systems in accordance with ICH Q7 • Main business segments: R&D / Biotech / CDMO / Specialty Pharma Companies, New Drug Delivery Technologies (NDA/505b2) – with heavy concentration on injectables, transdermal, nasal, inhalation, ophthalmic & sublingual drug deliveries Our products originate from our API manufacturing partner sites who are approved by the leading regulatory authorities, such as the US-FDA, EDQM, TGA, UK-MHRA, PMDA etc. LGM’s industry experience enables us to support our clients throughout the entire pathway of drug development, from discovery through commercial production. Based on the scale and scope of development projects with which we are involved, we are able to provide our customers with a seasoned perspective and valuable market insight. LGM Pharma has enhanced its position as a leading supplier of newly approved APIs, including full technical documentation and regulatory support. Our Clients: At LGM Pharma, our clients’ needs are our top priority, and we support our client base consisting of a diverse array of pharma companies, including: • Contract Research, Development & Manufacturing Organizations • Specialty Pharma and Novel Drug Delivery Systems • R&D & Biotech Companies • Generic Pharma Companies • Chemical Catalog Companies • OTC & Private Label Manufacturers • Academic & Government Laboratories • Pharmacy Compounding Industry

Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.

Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to degradable coatings that deliver cells over days, weeks, or months, we can create exclusive hydrogel formulations tailored for each therapeutic application. Likarda is the remarkable culmination of visionary leadership, science that is just as artistic as academic, and a compelling urge to do what’s right. As we move forward, we have well-defined, long-range goals with added opportunities for flexibility and growth.

Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records. Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint through end-to-end execution of clinical studies driven by technology and forward-thinking approaches to clinical operations.To date, Lindus Health has delivered clinical trials across the US, UK and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum, Firstminute Capital, and Seedcamp.

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 22,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Lyophilization Technology, Inc. is a unique Technical Service and Contract Development and Manufacturing Organization. LTI provides comprehensive in-house capabilities ranging from thermal analysis, product design, formulation development, process engineering, streamlining operations, improving compliance, preclinical to Phase II clinical material preparation and technical support for a wide variety of products. LTI has successfully developed formulations, manufacturing processes and prepared material for clinical trials for a wide variety of products. • Anti-infectives • Biologics / Vaccines • Oncolytics / HPCs • Small Molecules / Therapeutics Development Services are conducted with product quality and a manufacturing mindset from the start, considering product administration, stability and processing requirements. Distinct processing areas are comprised of ISO 5 clean rooms directly linked to pilot-scale lyophilizers. Clinical Manufacturing Area (CMA) is flexible for preparation of products with unique requirements, adheres to aggressive project timelines, and is fully cGMP compliant. • Pre-clinical to Phase II Clinical Material • Dedicated / disposable product contact items/equipment • Combined aseptic processing with product containment • Vials 2 to 100 mL and novel delivery systems • US / EU complaint Technical Services The broad range of experience in a wide variety of products provides a specialized expertise from which you can capitalize.

Lytic Solutions, LLC provides high-quality affinity reagents and molecular biology tools to the biological science researcher and offers customer-centric contract research & manufacturing organization (CRO & CMO) services.

Marken is the clinical precision logistics and advanced therapy subsidiary of UPS Healthcare. The UPS Healthcare network consists of 200+ locations worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 46 locations worldwide, while maintaining the leading position for cell and gene therapy services, direct-to-patient and home healthcare services, biological sample shipments and biological kit production. Marken's dedicated 2,600+ staff members manage 200,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 17,500+ home healthcare visits. Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry. Delivering What Matters From Clinical to Commercial.

Massive Bio collects and curates the latest scientific knowledge in genomics of cancer, connects with clinical information incorporate all new discoveries in treatment plans.

MatTek Life Sciences is at the forefront of tissue engineering and is a world leader in the production of innovative 3D reconstructed human tissue models. Our skin, ocular, and respiratory tissue models are used in regulatory toxicology (OECD, EU guidelines) and address toxicology and efficacy concerns throughout the cosmetics, chemical, pharmaceutical and household product industries. With facilities in the U.S. and Slovakia, MatTek's human cell-derived tissue models are widely used in the United States, Europe and Japan. Our record of scientific and technological innovation remains strong as we continue to develop and validate new in vitro assays, human tissue models and optically advanced cultureware. We invite you to use our products, services and technical solutions, which will afford your company new opportunities in obtaining faster, cost-effective, more reliable and human-relevant results compared to the traditional assays and 2D in vitro systems.

At Meadowhawk we recognize that the standard, cookie-cutter approach to CRO services is rarely the best option for any individual client or program. So rather than ask our clients to compromise for us we provide CRO services with flexible, fit-for-purpose study designs to deliver high quality data as quickly as possible. Offering a range of non-GLP services, our experts collaborate with you to find the right solutions for your study providing a single-point-of-contact to streamline communication.

Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated to making this world a healthier place.

MedChemExpress LLC, or MedChemExpress (MCE), is a biotech company based in New Jersey, USA, with locations in Princeton and Monmouth Junction. The company specializes in supplying high-quality research chemicals and biochemicals, including a vast selection of bioactive molecules such as selective inhibitors and recombinant proteins. These products are essential for pharmaceutical and life sciences research. MCE offers a variety of services to support research and development in the life sciences sector. Their services include custom synthesis for various compounds, protein expression and purification, and a comprehensive compound screening platform. They also provide molecular biology tools and cell biology services, which encompass cell culture and analysis. With a catalog of over 50,000 products, MedChemExpress is recognized for its contributions to drug discovery and research, serving a diverse global customer base in academia and industry.

Biopharmaceutical Company engaged in vaccine development against emerging viruses and biopharma CDMO manufacturing.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 43 countries.

Megadalton Solutions is a technology company that specializes in charge detection mass spectrometry for the characterization of large molecules, helping clients quantify AAV fractions and troubleshoot large molecule formulations.

Melior Discovery Inc (Exton, PA, USA) has pioneered a unique "high throughput" in vivo pharmacology platform (theraTRACE®) able to systematically identify novel indications for pre-clinical and development stage drugs. theraTRACE® is widely used by both multinational pharmaceutical and start-up biopharmaceutical companies alike to fully explore the therapeutic potential of their drug candidates. Melior has also leveraged this expertise to build a high quality, onshore, preclinical services capability offering in vivo efficacy models in a broad range of therapeutic areas, pharmacokinetic evaluations, specialized animal models and bioanalytical services to drug developers worldwide.

We bring together families, healthcare providers, and researchers to improve the quality of life for current and future patients. Our mission is to advance scientific and medical innovation through comprehensive patient-centric clinical research, in collaboration with our sponsors and providers. The Accel Research Sites Network offers leading sponsors, clinical research organizations and healthcare providers the ability to execute multi-phase clinical research studies. With a focus on precision and speed, our facilities are built for flexible, results-focused studies, able to be set up and executed on limited timelines. With decades of experience in the healthcare innovation space, you'll trust that every study, every patient, every outcome will be meticulously managed - with evidenced based results.

MRIGlobal is a world leader in applied science and technology research. We work with government agencies, commercial businesses, and academic institutions to provide independent research and innovative development. We are trusted partners steeped in technical excellence and a personal connection with each client. Contact us to learn how we can help you solve your program needs. We look forward to getting to know you.

Overview: To provide “best in class” genomic services for supporting our partner’s R&D capabilities solutions in the agriculture (plant and animal), pharmaceutical and industrial biotech industries. Experience: MOgene was formed in 2004, by industry leaders in genomic research. Over the years, the experienced team at MOgene have established themselves a solid reputation within the industry as the “go to” genomics service provider for academic, government and industrial research groups and institutions. Multiple studies have been presented and published in leading scientific journals, based on the genomic services provided by MOgene. Providing Results: The scientists at MOgene have years of experience collaborating with scientists in multiple biotech industries to provide solutions for their research. There have been over 100 publications from both large and small research companies utilizing data from MOgene services. Specialties: PacBio Sequel, Illumina Next Gen Sequencing, MicroArrays, QuantiGene and ProCarta Multiplex Assays, Nucleic Acid Extraction, qPCR, Clinical assays utilizing Arrays and NGS, plus full bioinformatics capabilities.

Molecular Depot is a biochemical company located in San Diego, California that specializes in developing research tools such as Specialty Bacterial Culture Media, Antibodies & Antigens, Enzymes & Proteins, Chemical Compounds & Molecular Conjugates, Research Kits, Reagent Stabilization Solutions. They also provide consulting and research services related to their products.

Montana Medical Researchis a dedicated independent research center that specializes in the management and coordination of phase II-IV clinical research trials.

We are an advanced mass spectrometry specialty lab offering analytical services and discovery opportunities in small molecules & peptides, proteomics, and metabolomics. We support numerous animal trials (veterinary, preclinical, pK, novel API & metabolites, etc.), drug discovery markers (metabolic and drugs), toxicology, and R&D. Our R&D support offers novel research expertise in proteomics & metabolomics, including informatics analysis.

nanoComposix is a world leading manufacturer of precisely engineered and highly characterized nanoparticles. Our mission is to help our customers bring nanotechnology-enabled products to market. Our multi-disciplinary technical teams provide rapid prototyping, characterization, integration, and scale-up solutions to accelerate R&D and commercialization for a wide variety of application areas including biodiagnostics, topical therapeutics, nanomedicine, antimicrobial coatings, and color engineering. Since 2004, nanoComposix has provided monodisperse and unagglomerated metal and metal-oxide nanomaterials to thousands of customers. Hundreds of different variants of material, size, shape, and surface are available as stock products and we have produced over 2000 custom core/shell, biofunctionalized, fluorescent, and magnetic nanocomposites to meet client specifications. All of our materials are supplied with certificates of analysis that include electron microscopy, hydrodynamic diameter, and optical data for each batch to guarantee products meet specifications. Contract manufacturing is performed on scales that range from small beakers to thousands of liters. Nanomaterials for medical devices and clinical trials are produced in our ISO 13485* and cGMP compliant cleanroom facility. By leveraging our unique library of nanomaterials, we aim to help our customers rapidly bring nanotechnology-enabled products from conception to commercialization. About Fortis Life Sciences: Fortis Life Sciences is a strategic platform providing capital, expertise, and operational resources enabling the growth and success of founder-led life sciences tools companies. Fortis Life Sciences was founded in 2020, with the vision of creating an exceptional life sciences company focused on offering world-class products coupled with a best-in-class customer experience. *For products manufactured under the scope of the ISO 13485 certification

Nanosyn is a privately held company founded in 1998, originally known as Nanoscale Combinatorial Synthesis. Established by chemists from the Soviet Union, Nanosyn focuses on providing efficient discovery chemistry services to pharmaceutical innovators, particularly emerging biotech firms. As a full-service Contract Development and Manufacturing Organization (CDMO), Nanosyn offers a variety of services to accelerate drug discovery. These include advanced chemistry solutions, biology services with high precision microfluidic-based assays, and support for the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and formulations. The company serves a diverse clientele, including small to mid-sized pharmaceutical companies, top 50 pharmaceutical firms, and academic institutions. Nanosyn has expanded its operations, including a branch in Research Triangle Park, North Carolina, and has a self-sustaining business model with reported revenues of $21.5 million. The company employs around 25 people and is recognized for its collaborative approach and commitment to delivering high-quality, cost-effective solutions.

Drug discovery contract research

With unrivaled expertise in immunology, 5 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q² Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic and oncologic fields. Our versatile team of scientists, working with state of the art technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines and biologics, anti-viral drugs, immunotherapy, gene and cell therapy products.

NEXT Bio-Research, Services continues a 23 year history in providing comprehensive integrated project support to investigators in the biotech and pharmaceutical sectors. We also provide medical testing services to physicians using state-of-the-art platforms. NEXT Bio-Research Services was founded by three long standing colleagues who have worked together these past 23 years and collectively represent more than 100 years’ experience in life science technologies. NEXT Bio-Research Services is focused in (1) clinical testing using molecular and biochemical techniques; (2) molecular genetics of pharmacogenomics and cancer; (3) contract research in drug discovery and development with private sector customers; and (4) laboratory support of human clinical trials. We function as an extension of your own laboratory in helping you to bring their products from discovery to market. Our laboratories are certified under the Clinical Laboratory Improvement Amendments (CLIA) act and our contract research services are offered individually or can be integrated to support product development from discovery to market with full regulatory support under FDA GLP Guidelines 21 CFR 58.

Nimble Therapeutics is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs. The Nimble platform combines massively parallel solid-phase synthesis, unrivaled chemical and structural diversity, sophisticated assays, and powerful machine learning and computational methods.

Norac Pharma is a preferred California-based API contract research and manufacturing organization offering close partnership in bringing drugs to market through excellence in process development, analytical services and cGMP manufacture of Active Pharmaceutical Ingredients (API's) & intermediates. With over 40 years of API experience, including expertise in Controlled Substances and Potent Compounds, Norac Pharma delivers timely, efficient, and regulatory-compliant service in support of your API development needs. Our excellent track record in successful project delivery along with our extensive experience justifies your confidence in our ability to deliver, irrespective of target chemistry complexity. Exceptional Chemistry - Creative Solutions

With over 20 years of expertise, NorthEast BioAnalytical Laboratories LLC, also known as NorthEast BioLab, specializes in providing top-notch GLP and clinical bioanalytical services. We are proud to be trusted partners to hundreds of industry sponsors and renowned investigators in the biotechnology sector. We are an independent, full-service facility that adheres to GLP/GCLP compliance. Our FDA-audited and DEA & CT State Schedule II-IV approved facility is managed by Watson LIMS, ensuring seamless operations. Our dedicated scientists and project teams excel in assay development, optimization, troubleshooting, and full method validation on various platforms, including Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and dPCR). With our custom assay development services, we offer comprehensive solutions for pharmacokinetics analysis studies, toxicokinetic safety testing, immunogenicity assay, multiplex cytokine analysis, PD biomarker assessment, biochemical assay, mechanism of action, gene expression, copy number variation investigations, etc. Since its establishment in 2003, our team of dedicated biologists and chemists has been committed to empowering mission-driven biotech. With our vast experience and technical expertise, we deliver exceptional preclinical study and clinical assay development services as a Contract Research Organization (CRO). At NorthEast BioLab, we prioritize top quality and industry-leading turnaround time while offering highly competitive pricing. Our team is dedicated to helping you meet the stringent timelines of various milestones throughout your drug development life-cycle. SPEAK TO OUR SCIENTISTS today to expedite your bioanalytical assay development, validation, and sample analysis!

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis' scCO2 technologies exceed the highest standards for product safety and performance. These processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials that are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials, such as allograft tissue, without damaging the product's structural or chemical integrity. NovaSterilis serves a variety of markets, including complex medical devices, drug delivery, tissue engineering, biotherapeutics/API, and additive manufacturing. With NovaSterilis, you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

Novatein Biosciences is a rapidly growing biological reagents company specializing in the production and supply of immunoassay kits, reagents and proteins to the researchers worldwide. We supply more than 10,000 different types of proteins and antibodies, and have one of the richest supplies of validated ELISA kits. In addition, we function as a contract research organization (CRO) assisting our clients in protein/ antibody production and immunoassay development and setup. As a manufacturer of reliable ELISA kits, our scientists are experts in performing and troubleshooting different types of sandwich assays including ELISAs. Our laboratory in Woburn, MA is equipped with BSL2 cabinet, CO2 incubator, shakers, incubator-shakers, ELISA plate washer, ELISA plate reader, protein spotter, array imager, FRET and alphascreen plate reader, qPCR cycler, gel documentation system, freezers, refrigerators, fume hoods, centrifuges, pH meter, western blot apparatus, PCR machine, FPLC/HPLC instrument, microscope etc. Our mission is to accelerate R&D by providing high quality reagents and timely services. At Novatein Biosciences, we firmly believe that we can only reach our potential as a company when our clientele succeed with their independent research goals. As such, we are completely committed to becoming a key partner for each of our clients’ biomedical research needs.

Novex Innovations is a true CDMO (Contract Development/Manufacturing Organization) supporting our clients efforts in the commercialization of their products. Our areas of operation include: Biological Formulations Clinical Formulation Tissue Processing Bioengineered Tissue Active Pharmaceuticals Diagnostic Materials Medical Devices Development to Pre-Clinical to Commercial Regulatory Support Storage & Distribution & Order processing services. Scale-up optimization Product characterization Manufacturing through all phases of clinical trials Commercial modeling, manufacturing, and distribution Proof of concept Our clients range from single person operations to multinational companies. We provide process development, manufacturing, storage, and product distribution, all under cGMP procedures and policies. We operate cleanroom space at Class 1,000 and smaller scale spaces at Class 100, all for clinical and commercial manufacturing. Our Quality System is regularly monitored to the current ISO 13485 standards by BSI. Novex is also registered with the FDA. Our customers are both national and international and have a good understanding of other regulatory agencies as well. Customers have the option of storing their products at and having Novex ship on their behalf.

Nth Analytics pharmaceuticals consultants: CDISC SDTM/ADaM, biostatistics, and SAS programming.

Olon Ricerca Bioscience is a pharmaceutical company that specializes in Active Pharmaceutical Ingredients (API) contract development and manufacturing, as well as generics supply.

Olympic Protein Technologies is a contract research organization focused on providing high quality protein science services for clients and partners. The quality of proteins are vital to the success of experiments that form the foundation of the discovery and development of therapeutics. Our staff has a wealth of collective experience in top-tier biotechnology companies successfully designing, producing and characterizing protein therapeutic candidates as well as critically important antigens and reagents. This experience includes solving problems associated with the expression/purification of challenging proteins. The aim of our team is to leverage this knowledge to provide the best experience and outcomes for our partners and clients by providing quality science delivered with full engagement and the highest standards, integrity, and data security. We currently offer construct design, expression, protein production & characterization, biomolecular interaction analysis, antibody generation, and protein engineering services. We also can leverage our network of protein science contacts to provide access to other types of analyses, such as advanced biophysical technologies, for your project. As we grow we will build on our existing capabilities while broadening our offerings to include other protein science services. We are located in Seattle Washington USA.

A Chicago-based medical device development firm partnering with entrepreneurs, startups and large organizations worldwide to bring their innovations to life.

ORGANIX, has recently joined the Symeres family which begins an exciting new chapter for employees on both sides of the Atlantic and for customers, new and existing, across the globe. The two companies come together as perfect partners in delivering exciting, exceptional services and an unmatched enthusiasm for organic chemistry. ORGANIX a Massachusetts based corporation established in 1986, conducts research and development under contract in organic chemistry and all related areas. The company is located about thirty minutes from downtown Boston and Logan International airport. ORGANIX can assist you in the pursuit of your research and development goals. ORGANIX provides a cost effective and confidential means of carrying out short and long term synthetic chemistry without the need to hire additional scientists. The Company's highly trained staff can attend to your needs (milligram to kilogram) in a timely and professional manner. Symeres is one of Europe's largest small molecule CRO (Contract Research Organization) and CDMOs (Contract Development and Manufacturing Organization) Headquartered in the Netherlands it has a headcount of about 600 working at locations in the Netherlands, the Czech Republic, and the Nordics. Around 60% hold a PhD

Pace® Science and Technology Company makes the world a safer, healthier place. We partner with clients to provide the service, science, and laboratory data needed to make critical decisions that benefit us all. Through a nationwide laboratory network, Pace® advances the science of businesses, industries, consulting firms, government agencies, and others. ANALYTICAL SERVICES Pace® Analytical Services is a division of Pace® Science and Technology, providing local testing and analytical services backed by a large, national laboratory and service center network. Through in-lab, mobile, and emergency onsite containment and regulatory services, we ensure our air, water, soil, and more are safe for our communities and lives. LIFE SCIENCES Pace® Life Sciences is a division of Pace® Science and Technology committed to advancing the science of the pharmaceutical and biopharmaceutical industry by providing full-service CDMO/CRO capabilities and professional services for in-house labs through a nationwide network of service centers, manufacturing sites, and FDA-registered laboratories. COMMITMENT We believe the work our customers do is important to improving our communities and lives and are committed to supporting them through strong partnerships, delivering upon expectations, and providing exceptional customer service.

PackGene is a world-leading AAV vector packaging CRO and CDMO. Founded in Massachusetts, USA, PackGene now has offices in Boston, Houston and Zurich. We work with customers to support gene therapy programs from early-stage R&D, preclinical development, to IND studies. Our mission is to accelerate gene therapy product development by providing an integrated one-stop solution including plasmid, viral vector, fill-finish and QC analytical services for the gene therapy industry.

Contract R & D

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster.

Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown to become a community of approximately 19,000+ workers who support over 7,000 products for over 1,000 customers around the world. We share a common goal: to put patients first and help people around the world live better and healthier lives. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results. more products. better treatments. reliably supplied.™ Your talents, ideas, and passion are essential to our mission: to develop, manufacture, and supply products that help people live better, healthier lives. Join us! Catalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech, and healthcare companies, will help bring life-enhancing products to life. Grow with us. Be challenged. Make a personal impact. Visit https://careers.catalent.com/us/en to explore career opportunities

The Lubrizol Corporation, a Berkshire Hathaway company, is a specialty chemical company whose science delivers sustainable solutions to advance mobility, improve wellbeing and enhance modern life. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has more than 8,000 employees. For more information, visit www.Lubrizol.com.

PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. With 30 sites across Australia, Canada, North America, the UK, and Europe and over 6000+ dedicated employees, together, delivering life changing therapies. Leading technology and continued investment enable us to deliver development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.

PCM Trials is leading the way in mobile research and decentralized clinical trials. Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the flexibility to engage in research studies in the ways that work best for them and expanding opportunities for participation. PROVEN RESULTS Faster Enrollment | Higher Retention | Improved Adherence | Greater Diversity | Uncompromised Data Quality PCM Trials has worked on 270+ protocols for 130+ sponsors and done 29,000+ visits.

Helping medical device Sponsors improve healthcare since 1967, NAMSA is the world's leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients' products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, NAMSA is the industry's premier, trusted partner for successful development and commercialization outcomes. Learn more: https://namsa.com/about/client-testimonials/

Performance Validation, a 100% Employee-Owned Company has been serving the life science industries since 1988, and is a nationwide leader in providing validation, commissioning, and construction quality services for pharmaceutical, biotechnology, and medical device manufacturers. We provide the Life Science industries with technical and consulting expertise to help companies achieve and maintain regulatory compliance. We strive to provide our customers with peace of mind with respect to the management and accomplishment of project work entrusted to us. We accomplish this through: executing our services with integrity, demonstrating teamwork in providing solutions, and treating employees and customers with respect and professionalism.

Phesi has the industry’s most comprehensive and dynamic clinical trials database and predictive analytics tools to help trial sponsors make quick and informed decisions to expedite drug development. Our distinguished team works side-by-side with its clients to analyze data, answer questions, and offer informed solutions to benefit study sponsors, investigators, and ultimately patients. Phesi has been applying its innovative technology and deep expertise to help life sciences companies for over 10 years. Our experts work with study sponsors to drive solutions from clinical development planning through trial implementation to optimize protocol designs, select the best investigator sites, shorten enrollment cycle times, select and manage CROs, and much more.

We sequence whole plasmids, amplicons, whole bacterial genomes, and colonies overnight, without the need for primers and minipreps. Plasmidsaurus is on a mission to accelerate new cures and promote a healthier planet by unlocking new levels of productivity in scientists using DNA tools to bring their ideas to life. The company’s DNA sequencing services are used daily by thousands of innovators, including Nobel prize winners, dynamic biotech startups, pharmaceutical companies, research labs, and DIY biohackers. Plasmidsaurus’s global network of labs operates day and night to enable world-changing discoveries.

Pluristyx is a pioneering company at the forefront of stem cell technologies. With a mission to revolutionize the field of regenerative medicine, Pluristyx develops innovative solutions that empower breakthroughs in stem cell therapies. The company's proprietary platform, panCELLa, represents a transformative leap in stem cell research, offering enhanced freedom to operate and unparalleled potential for medical advancements at a significantly accelerated timeline. Operating from two cutting-edge North American sites, Pluristyx is dedicated to driving progress and innovation in the realm of stem cell therapies. In July of 2023 Pluristyx and panCELLa merged. Pluristyx offers a portfolio of iPSC-based products and services to provide end-to-end client support in early product development, while panCELLa offers an array of unique and effective technologies with particular strength in gene editing. As one company, Pluristyx and panCELLa offer an enlarged portfolio whose long-term focus is to become the global leader in clinical-grade, genetically modified, “off-the-shelf” iPSCs with the lowest barrier to entry for cell therapy development, providing clients with the fastest speed to clinic and the best route to commercialization.

PolyOrg, Inc., founded in 2003, provides comprehensive chemical synthesis services to life science companies and research universities. We help our customers develop new products, improve existing products, and transition their existing products from research to manufacturing. We perform contract research, process development, custom synthesis, and manufacturing for clients in various science industries. Our clients are primarily in the pharmaceutical, biotechnology, specialty chemicals, and diagnostic industries. We employ expert Ph.D. chemists and process technicians skilled in organic, solid phase, medicinal, natural product, and polymer chemistry. For inquiries or quotation requests, email info@polyorginc.com.

PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.

Prana BioSciences Inc., is an early-stage hybrid biotech and biomanufacturing company. We envision a world where all people living with a disease that can be best treated with a biologic should have access to one. Our steadfast mission is to develop, and manufacture cost-effective "biobetter" versions of the world's most successful monoclonal antibodies (mAbs) for a broader patient population. We are a biotech merging robust, established best-practice antibody development practices with advanced AI-supported enhancements in binding, function, and patient safety. We have our own identified four “biobetter” versions of the world's most successful monoclonal antibody targets, which come with new intellectual property. Along with serving as a catalayst for governments, to build a bio-tech development hub, we also have a biomanufacturing center with a proprietary manufacturing platform featuring our own vector, cell line, and processes to develop customized therapeutic mAbs for itself and offer excess capacity as Contract Development & Manufacturing Organization (CDMO) services to other biotech firms. And to achieve our patient ambition we have a seasoned leadership team of inventors, scientists, commercial specialists and big thinkers combining deep expertise to develop, register, manufacture and commercialize antibody-biobetters in a quest to deliver life-transforming medicines that can profoundly impact patients’ lives.

Precision for Medicine is an industry-leading global clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 dedicated professionals and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.

Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients' insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 dedicated professionals and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.

Promedica International is a privately held, full service CRO providing clinical trials for the medical device, biotechnology and pharmaceutical industries. Founded in 1985, Promedica International, a woman-owned corporation, is headquartered in Orange County, California. We have successfully been providing exceptional value to our clients for over 35 years.

PROMETRIKA, LLC is a full-service clinical research organization serving the pharmaceutical and biotechnology industries in the areas of clinical operations, pharmacovigilance, data management, biostatistics, medical writing, and regulatory submissions. With our expertise and extensive experience in managing clinical trials, and analyzing and interpreting medical data, we serve as outsourcing partners to our client companies and institutions.

ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms. Our deep history of analytical leadership in protein-based therapeutics stems from the merger of Protagen Protein Services in Europe and BioAnalytix in the US. In 2021, GeneWerk’s unique capabilities in vector safety, integration site analysis, and bioinformatics were added to our portfolio, establishing ProtaGene. Our combined protein- and gene-based analytical platforms make it the leading analytic service provider across the biopharmaceutical and gene and cell therapy development spaces. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide.

Proteos is committed to providing a quality foundation for drug discovery. We are a contract research organization that provides the highest quality recombinant protein expression and purification services for drug discovery research in the biotechnology and pharmaceutical industries. Our highly-skilled team of scientists utilizes diverse experience and optimized methods within a customized workflow that focuses on the end product from square one. Fully customized experimental designs allow flexibility and adaptation during the project, thus enabling data-driven decisions that lead to a higher probability of project success. Proteos is passionate about drug discovery. We know that reliable reagents are critical for the ultimate success of drug discovery programs.

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic. With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients. Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

Founded in 1988, Pyramid Labs is a Drug Product CDMO specializing in injectable drug product development and manufacturing. Our capabilities include: • Clinical and Commercial Vial & Syringe Fill/Finish • Clinical and Commercial Lyophilization • Liquid Drug Product Formulation & Process Development • Lyophilized Drug Product Formulation & Cycle Development • PPQ and PV for late stage Drug Products • Labeling & Packaging • Quality Control Laboratory Services- In-process, Lot Release & Stability • Analytical Method Development & Validation • API & Drug Product Stability Studies

Q Laboratories is an ISO/IEC 17025 Accredited, cGMP/GLP compliant, FDA Registered laboratory, that provides microbiology and analytical chemistry laboratory services to companies around the world. Q Laboratories can perform analyses on food & beverages, raw materials, pet food, pharmaceuticals, cosmetics, OTCs, dietary supplements, medical devices, and health and beauty care products.

Quantigen serves as both a contract research organization (CRO) and an active patient diagnostic laboratory. We employ a highly collaborative, cross-disciplinary approach when formulating the best strategy to meet each client's unique translational needs. Our scientists, drawn from across academia, big pharma, and clinical laboratories, work in tandem during project planning and execution to deliver cutting-edge solutions: ones that ease the transition from bench to bedside. Whether performing diagnostic protocol optimization, biomarker development and validation, medical-device design, or early-phase clinical trials support, Quantigen leverages the insights of a diversely trained team to design projects that help to ensure a successful lab-to-clinic transfer process. For further information, contact us at: contact@quantigen.com.

QuickBiology is a fully automated, high-throughput genomic center equipped with all major next generation sequencing. QB provides state-of-the-art genomics technologies, comprehensive services, specialized expertise enabling these services in a cost-effective and timely manner to serve basic science and translational/clinical research. QB’s service included, but not limited to, RNA sequencing, whole exome sequencing, whole genome sequencing, ATAC sequencing and single cell RNA sequencing.

Quintara Discovery is a Contract Research Organization that supports biotech, pharma, and academic organizations in pre-clinical space for molecule discovery and development.

RapidTrials uses our experience and deep life science and healthcare industry relationships to boost site and study performance. Using tested evidence-based methods to strategically assemble the finest talent and teams in the industry, we produce measurable results that matter, expediting patient access to groundbreaking treatments. With access to tens of thousands of specialized life sciences and healthcare providers, we carefully screen candidates based on your needs, ensuring that they are being met by talent with the right skills and experience—temporary contractors, direct hires, or part-time and full-time staff. Principal investigators Sub-investigators Research nurses, study nurses, nurse practitioners Clinical research coordinators Research pharmacists Psychometricians Patient recruitment and retention specialists Patient escorts Social workers, physical therapists, respiratory therapists, nutritionists Clinical data coordinators Data abstractors Healthcare professionals

From Molecule to Market: Your Trusted Partner... Raybow USA (formerly PharmAgra) in Brevard, North Carolina, is a division of Jiuzhou Pharmaceutical, a CDMO with headquarters in Linhai, Taizhou City, in Zhejiang Province, China. Raybow USA, with over 20 years in R&D and Analytical Chemistry, is now your gateway to global power. Your big idea can start small and then fluidly scale up to medium, large, or super-sized production –all with the same North Carolina connections you’ve come to expect. Jiuzhou Pharma understands that bringing a molecule to market is not just about chemistry—it’s about trust, collaboration, and expertise. With years of proven excellence in the CDMO space, Jiuzhou Pharma has become a global leader in small molecule, nucleotide and peptide development. Raybow USA can help take your vision from concept to commercial reality—quickly, efficiently, and with the utmost precision. Let’s work together to shape the future of health! Why Jiuzhou Pharma? ✔ Comprehensive Solutions: support for your molecules from early-stage R&D to full-scale commercial manufacturing ✔ Expertise: deep scientific knowledge to deliver innovative and efficient solutions for small molecule and Tides CDMO services ✔ Global Reach, Local Focus: European and American subsidiaries tailor global CDMO services for specific regional markets ✔ Customer-Centric: committed to your success through partnerships based on transparency, reliability, and shared goals ###

Reaction Biology provides scientists worldwide with a trusted research partner supporting all phases of preclinical drug discovery from target validation through hit identification, hit to lead and lead optimization. Our portfolio covers most of your needs in drug discovery – over 2,000 biochemical targets, hundreds of cell-based assays, an extensive array of in vivo oncology models, along with custom assay development and protein production. Our team of Ph.D. scientists will provide you with collaborative support, quality data, and excellent communication, for a superior research result. Our target categories include kinases, epigenetic targets, proteases, PARPs, and many more. We also offer a line of high-quality epigenetic and kinase proteins for sale. Assay platforms include radiolabeled and fluorescent biochemical assays, biophysical assays, ion channel, cell-based assays including a wide array of target engagement assays, and in vivo oncology models including our SubQperior tumor models. From our labs in the US and Germany, Reaction Biology performs research projects for customers around the globe on a fee-for-service basis and as an integrated partner, and we would be delighted to support your research needs, too. Let's discover together.

Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.

Resero Analytics creates software and data products to help Pharmaceutical companies, CROs, and Regulators to better manage their Data, to apply Analytics that will extract more value from their data, and to Report it more promptly and more accurately. Our primary focus is on Toxicology and its translation to human drug safety.

Collaborating on all therapeutic modalities, Resolian fuses expertise from Alliance Pharma and Drug Development Solutions to provide world-class scientific solutions. We are an ever-expanding global team of experts, resolute in our goal to offer an accessible, enhanced customer experience through a personalized approach and proactive management. With Resolian Bioanalytics, our vast expertise, from next-generation biologics to cell and gene therapy, allows us to find solutions to the most challenging bioanalytical methods and assays. Resolian Analytical Sciences builds on two decades of experience solving the most complex challenges in testing raw materials, formulated products, packaging and medical devices for trace impurities, contamination, degradation and quality control. Learn more about us at resolian.com.

RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment assembly technology gives life science researchers, drug developers and synthetic biologists unprecedented access to accurate, long synthetic genes and their functional readouts. We enable biology at scale.

RTLGenomics is a full service sequencing company offering sequencing approaches including barcoding, metagenomicsand transcriptomics. A sister lab, MicroGen, is a CAP accredited clinical diagnostic laboratory.

Rubix LS: The Health Outcomes Architect At Rubix LS, we drive innovation in clinical research, drug development, and public health by combining cutting-edge science, real-world data, and inclusive patient engagement. Our work is structured around three core pillars: 🔹 Investigator-Led Research – We conduct our own research and develop targeted solutions to accelerate new therapies and improve health outcomes. 🔹 Clinical Research Services – We collaborate with biotech, pharma, and life sciences companies to manage clinical trials, support regulatory submissions, and enhance patient diversity in research. Our work is powered by 18M patient data sets and 369M patient data points. 🔹 Government & Public Health – We partner with federal agencies and public health organizations to develop policies, improve disease surveillance, and advance health equity through data-driven solutions. Leveraging Environmental & Geographic Insights To better understand health risks and intervention strategies, we integrate: ✅ DoE data to analyze long-term environmental exposures. ✅ USDA data to study the impact of food and nutrition on health. ✅ Heat Sink data to model cancer risk and environmental disease patterns. At Rubix LS, we don't just conduct research—we build pathways to better health by ensuring therapies are developed, tested, and delivered with precision, equity, and impact. 🔗 Learn more at our website.

Saama develops life science solutions that accelerate the delivery of therapies to patients. With innovative AI technologies, Saama drives breakthrough intelligence into clinical and commercial operations. The Saama platform powered the clinical trial that led to the world’s first COVID-19 vaccine. Headquartered in Campbell, CA, with employees around the globe, Saama is committed to helping customers save and improve lives. Discover more at saama.com.

Based on RUCDR Infinite Biologics, which was founded in 1999 to provide biobanking services and biomaterials to advance the genetic disease research of partners in the public and private sectors. Following the spinout, Infinity Biologix said it will provide sample collection, processing, storage, and analytical services integrated with scientific and technical support in both the research and clinical arenas.COVID-19: COVID-19 Saliva test. In April 2020, IBX (formerly Rutgers RUCDR Infinite Biologics) received the first FDA Emergency Use Authorization (EUA) enabling the use of saliva tests to detect the presence of the SARS-CoV-2 coronavirus. Since then, a revised EUA for anat-home saliva sample collectionwas also approved.

Sannova is a boutique CRO with a unique Z factor approach, prioritizing high standards and exceptional services for clients. We offer fast, personalized, end to end analytical and bioanalytical services for complex, novel, and generic therapeutics. Our core values of quality, speed, and flexibility enable us to deliver exceptional results via our passionate team of expert scientists. Our commitment to reliable and reproducible results gives clients confidence in their therapeutic development.

Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development. Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers – including metabolites, lipids, and proteins – across thousands of samples at a time. These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data; robust quality control analysis; and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures. Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.

Science 37's mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the Metasite™ and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration.

Scintillant Bioscience provides in vitro biology services for therapeutics discovery and preclinical development for all therapeutic modalities. We help clients with all aspects of drug discovery projects, including screening, hit-to-lead, lead optimization, and preclinical development. We develop, validate and implement cell-based assays, typically for high content imaging (HCI)/high content screening (HCS)/high content analysis (HCA) and other forms of automated microscopy, including time-lapse imaging. Additionally we provide a variety of other services, such as plate-reader assays, proteomics, molecular biology services and more. We are happy to work with you on any of your needs for biochemical or cell-based assay development, validation or implementation. We have developed drug-discovery assays using primary cells, cell lines and iPSC-derived cell types. We will custom build stably overexpressing-, mutant- or reporter-gene cell lines as required for your drug-discovery programs. Let us help with your drug-discovery challenges.

An oncology-focused Contract Research Organization (CRO) based in La Jolla, California. SciQuus Oncology offers a broad range of services to the pharmaceutical and biotechnology sectors. The experience of SciQuus management spans the development lifecycle from pre-IND studies to the management of large registration trials.

Scisco Genetics Inc, a Seattle-based spin-off from the Fred Hutchinson Cancer Research Center, is a leading provider of sequencing services and products for genotyping the immune system.

Seragon Pharmaceuticals Inc. is a pharmaceuticals company based out of Irvine, CA. The Company was founded by scientists dedicated to leveraging their expertise in biomedical research to improve the quality of human health. Our products reflect years of experience in various clinical, biomedical and research environments. We strive to bring the most advanced health optimization and longevity products to the market by utilizing our knowledge and experience in various specialties. Additionally, we offer various laboratory and consulting services to our partners in industry. Seragon operates state-of-the-art biological research and testing facilities, which provide invaluable services to our strategic associates. Although our portfolio represents years of knowledge and progression, each step forward has shown us how much progress there is still to be made. Seragon is a growing team of gifted scientists, researchers, and creative minds dedicated to innovation, and playing a key role in redefining health care for the consumer. Our purpose is to drive innovation forward, with vigor and an unwavering passion to identify the gaps in modern medicine, by producing ethically sound, tangible health care options that make sense to the consumer. Utilizing collaboration, exceptional talent, principled business practices and a firm grasp of our industry. Seragon paves the way in expanding a universal understanding of Longevity, Metabolism, Gene Therapy and Immunology. Our employees drive the kinetic and creative energies in the Seragon work culture, laying the groundwork for a self-perpetuating, open-minded think-space that results in original and imaginative thought. We believe flexibility of ideas and open dialogue promotes a nimble mind and gives our employees the right kind of environment they need to invent, develop and create the very best technologies in healthcare.

At Serán, Our mission is to provide optimized drug development and manufacturing services for our clients, from discovery to the clinic. Our science-driven approach utilizes predictive design tools, novel chemistry, analytical tools, enabling delivery technologies, and a thorough knowledge of quality and regulatory requirements to guide our customers on their clinical development path. Serán's team are experts in delivery of poorly soluble compounds. Serán employs a range of novel technologies and pharmaceutical manufacturing operations to overcome drug development challenges for both small and large molecules, including complex granulations, spray-dried dispersions, hot melt extrudates, IR and MR tablet technologies, multiparticulates, and engineered particles inhalation. Our custom-built spray driers enable a wide variety of particle formation, from nano-structures to micro-particulates. Our particle engineering approaches are combined with our broad expertise in solid dosage forms resulting in the optimum clinical trial materials for your drug, including suspensions, capsules, and tablets.

Singota Solutions is a cGMP compliant, FDA registered Contract Development and Manufacturing Organization (CDMO), providing the pharmaceutical industry with formulation development, supply chain and materials management, analytical testing, labeling and kitting services, and aseptic manufacturing. Founded in 2006, and headquartered in Bloomington, Indiana, Singota serves 200+ clients offering them superior, quality driven outsourcing services. The company assists its clients in moving their products from "the bench" to the market with quality, speed, reliability, responsiveness, innovation and transparency. Singota is heavily focused on continuously increasing the efficiencies of its services, thereby reducing drug development process lead-times.

Sirona Dx is a technical CRO, providing advanced, high complexity, single cell, multi omics services to accelerate the pace of immunotherapy and targeted therapy development. In contrast to most CROs, we embrace leading edge technologies at an earlier stage, often assisting life science companies with product development. Bridging the silos between tools developers and biopharma means our clients access enabling technologies and expertise sooner and within a CLIA accredited, GCLP laboratory that supports pharma regulatory requirements. Our team can assist with platform selection and with the design, optimization and validation of complex multi-analyte assays. Harness breakthrough technologies to profile and integrate biology with single-cell resolution including tissue spatial context to reveal the next generation of precision biomarker signatures to accelerate therapies towards regulatory approval. Recognized as the original pioneers of spatial biology we launched the first spatial-omics CRO service in 2018 utilizing IMC technology developed by Fluidigm. Today our technology agnostic, spatial biology suite includes all of the leading multiplexed imaging platforms. Our team can develop panels of up to 40 markers to reveal the complex interplay between the immune system and the tumor/tissue microenvironment. We leverage CyTOF technology from Fluidigm to perform ultradeep immune profiling of whole blood and PBMCs with highly multiplexed assays of 40+ markers. High performance RNA extraction methodologies coupled with a comprehensive menu of high parameter IO expression profiling assays supports exploration of complex tumor immunobiology from challenging sample types. From exploratory testing and biomarker development through to clinical trials support, we partner with you every step of the way. Contact us with your specific requirements and our team will guide you to the optimal assays and platforms to support your study.

Headquartered in Rancho Cordova, Calif., SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. SK pharmteco is comprised of six companies: SK Biotek Korea, SK Biotek Ireland, AMPAC Fine Chemicals, AMPAC Analytical Laboratories in the U.S., Yposkesi and the Center for Breakthrough Medicines.

Founded in 1925 and headquartered in Akron, Ohio, Smithers is a multinational provider of testing, consulting, information, and certification services. With world-class laboratories and operations in North America, Europe, and Asia, Smithers supports customers in the transportation, life science, packaging, materials, components, consumer, and energy industries. Smithers delivers accurate data, on time, with high touch, by integrating science, technology, and business expertise, so customers can innovate with confidence. Smithers invests in our scientific and engineering talent. Our scientists and engineers are key opinion leaders in many of the markets we serve.

SPECTRONRx provides therapeutic and diagnostic Isotopes for clinical and research use. They specialize in providing you flexible and efficient Contract Manufacturing and Contract Research services.COVID-19: EUA (O5/2020) Hymon SARS-CoV-2 Test Kit.

An independent non-profit institute headquartered in Silicon Valley, SRI is a global leader in research and development. We collaborate across technical and scientific disciplines to create a safer, healthier, and more sustainable future. For more than 75 years, SRI has had a profound impact on every one of our lives through the discovery and development of groundbreaking technologies and products and by bringing many of the world's most extraordinary innovations and ideas to the marketplace. Learn more at www.sri.com.

Stat One is a Contract Research Organization (CRO) providing expert consulting and statistical support for pharmaceutical, biotechnology, and medical device clinical trials. Our expertise is supported by three decades of industry and regulatory experience in the areas of statistical consulting, reporting, and data management. We emphasize efficiency and effectiveness when preparing your product for FDA approval. Stat One's experience covers a broad range of therapeutic areas and indications. Our team is your partner in growing a better future!

StemCellerant designs and manufactures stem cell based research tools and therapeutics with a mission to accelerate personalized regenerative medicine.

Sterling Pharmaceutical Services LLC is a full-service pharmaceutical contract manufacturer and formulation development expert that specializes in technology transfers, scale-up, and commercial manufacturing.

Established in 1962, St. Louis Community College is the largest higher educational institution in the region and the second largest in Missouri. STLCC has served more than 1.2 million students; at least one person in more than one-half of the households in the St. Louis area has attended the College.

Strata Oncology is a high-growth, state-of-the art, precision oncology company, delivering a new standard of care that integrates molecular profiling, decision support and clinical trial participation into routine practice. We do this by partnering with major healthcare systems across the country, who systematically send their cancer patients’ biopsies to our high-throughput CLIA lab for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matches to appropriate therapies and drug trials. This accelerates the move to personalized medicine – right medicines to the right patients at the right time. Our personnel are passionate about and committed to making a positive difference, now, in the lives of cancer patients and their families. Clinicians, pathologists, bioinformaticists, software engineers, lab technicians and more, coming together to give access to those without, uncovering insight that might be hidden, all while spreading urgency to all. Experience a career that connects a fast-paced team environment with a worthy pursuit – feel good about what you’ve accomplished at the end of every day!

Founded in 2004, Sundia MediTech Company, Ltd. is a leading pre-clinical contract research organization (CRO) providing a comprehensive and integrated portfolio of high-quality drug discovery and development services. Sundia's experienced R&D and international management team possess extensive experience across the fields of chemistry (custom synthesis, library design and synthesis), medicinal chemistry, biology (in vitro and in vivo), DMPK, pre-clinical studies, as well as pharmaceutical development (process research and development, API manufacturing, pre-formulation and formulation, analytical as well as QA/QC, CMC and IND filing) services. Sundia's primary research facilities, which include standard and kilo-labs, an animal facility, a pilot plant and other supporting facilities, are located in Shanghai (Zhangjiang Hi-Tech Park), Shijiazhuang and Taicang. For more information, please visit us at www.sundia.com or email us at info@sundia.com.

Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies.

Sword Bio is a bioanalytical CRO committed to delivering projects with the best-in-class quality, science, service, and speed. We are a team of experts in the bioanalytical CRO field, bringing over 30 years of experience to your project. We specialize in developing, qualifying and validating PK, Biomarkers and immunogenicity assays. At Sword Bio, we have the flexibility to respond to your evolving needs, from assay development to clinical testing in an Non-GLP or GLP environment. We will work with you to maximize your resources and begin your projects immediately, priding ourselves on timely results and open communication. Sword Bio offers a rapid, customized, collaborative and an accessible new way of working with a CRO. Sword’s mission is the same as yours: to quickly and reliably bring essential drugs to those who need them.

The newly announced merger of NY-headquartered Symbio LLC and CA-headquartered Dow Development Laboratories LLC with Munster (Germany)-based Proinnovera will form Symbio Proinnovera, creating one of the world's largest specialized dermatology-focused clinical research organizations. Founded over 20 years ago, the Symbio & Dow Group has a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client's dermatology and aesthetics services - from pre-clinical formulation work to subsequent clinical trial execution. Proinnovera was founded 25 years ago and is a leading European CRO in the dermatology clinical trial space. It is a full-service CRO conducting clinical studies from Phase I to IV, as well as non-interventional and medical device studies. Proinnovera turns study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials. Both companies are proven market leaders among specialty dermatology CROs with exceptional geographical coverage. Their combined strength will enable them to excel at addressing customers' needs and expectations in all areas of research. The newly formed organization will leverage the combined power of two highly experienced teams with deep expertise in the dermatology space to generate efficiencies and accelerate clinical research. Symbio Proinnovera will be supported in its growth by ARCHIMED, a leading investment firm focused exclusively on healthcare industries.

Tara Innovations LLC is formulation contract research organization (CRO). We specialize in product development, technology management, analysis, and process development. We do preformulation and pharmaceutical consulting. We are expert in nanotechnology.

Techverse, Inc. is a contract research and development firm in advanced energy generation and utilization concepts with a focus on improving energy efficiency.Techverse, Inc. is developing a membrane filtration-based algae dewatering process to produce algae paste.

TEDOR Pharma Services is a science-driven Contract, testing, Drug Development, and Manufacturing Organization (CDMO). partnering with your team to provide solutions and services for analytical testing; drug dosage development; clinical supply, packaging, distribution; and commercial manufacturing. DEA-scheduled products I-V; high potency; powder biologics; small manufacturing batches and orphan drugs for life science customers. TEDOR has helped customers meet their project timelines, achieve regulatory approvals, and solve formulation challenges. TEDOR Pharma employs skilled and specialized experts that support a wide range of capabilities that include: •Drug Product Development • Analytical Testing • Quality Assurance • Legal Compliance • Regulatory Filing • cGMP Manufacturing • Commercialization Our dynamic work environment provides a great opportunity to learn and grow professionally. We offer competitive wages and benefits, and our employees have the opportunity to drive innovative technologies, setting industry trends. TEDOR is an Equal Opportunity Employer.

At Terrain Bio, we help RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, we bring unparalleled speed and quality to RNA manufacturing.

ADVANCING HEALTHCARE WITH HEART CREATE YOUR FUTURE, AND OURS Here you grow your own way, you create to innovate, and learn as you go, alongside like minds who share the same commitment to the future of healthcare. We are proud to have launched global development programs to help our associates shape their careers alongside the future of healthcare. ENJOY A REWARDING AND MEANINGFUL CAREER As a team, we make a real difference to the health and wellbeing of our patients today, and leave a lasting legacy for tomorrow. Your time is dedicated to innovation, problem solving, teamwork and lifelong learning, as an integral part of our ever-curious, always committed, continually collaborative environment. We foster a growth mindset culture, embracing mistakes as an opportunity to learn, and celebrating the small wins along the way, so we can all grow together. FOR TERUMO, FOR EVERYONE, EVERYWHERE Whatever you do – marketing, engineering, sales or manufacturing – our teams look out for one another, respect and support each other in achieving our goals, and we value diversity and inclusion, empowering everyone to bring their authentic self to work. If you’re ready to advance healthcare with heart, we look forward to hearing from you.

Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based assays/potency assays during development - Immunogenicity, TK/PK, ADA and neutralizing Antibody Testing - Immunotoxicology studies - Sample pre analytics: serum/plasma isolation, PBMC isolation & storage - Biobanking - Read-outs: ELISA, ECLIA, Flow cytometry, ELISpot, HAI, proliferation... Texcell Viral Safety lab: Expertise in biosafety of biological and pharmaceutical products. - Virus/TSE Validation - Viral Clearance study - 25 model viruses available - spiking in L2 and L3 labs... - Viral safety testing - a complete range of tests (NGS, in vitro, in vivo, TEM, Q-PCR…) to characterize cell banks and ensure microbiological safety (viruses, mycoplasma, etc…). - Cell and Gene therapy (ATMPs) and Biodistribution/biodissemination - experience with adenovirus, retrovirus, lentivirus... - Virucidal Norm and cleaning validation - Standard Toxicology and Medical Device Biocompatibility studies (ISO 10993) Texcell GMP cell bank facility: Expertise in handling and growing more than one hundred mammalian cell lines. - Production of RCB, MCB and WCB in GMP - Modern class B and class C cell culture room - Dedicated class B room to fill automatically cells in vials - Culture of adherent and suspension cell line with single use disposable - Viral safety control of cell banks performed directly in-house For more information visit www.texcell.com.

Therapeutics Inc. is a drug research and development company focusing on integration of clinical and regulatory strategies, trial design, product development, and marketplace analysis. The company's services include clinical development project management, medical monitoring, and non-clinical development such as designing and managing pharmacology and toxicology programs. Therapeutics develops drugs and devices for acne, psoriasis, melasma, excess facial hair, injectable fillers, photoaging, and onychomycosis. The company was founded in 1997 and is headquartered in San Diego, California.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

TopoGEN is a research diagnostics company that provides innovative products and services for researchers working with topoisomerases and engaged in mechanism based drug discovery and development. The company was created by topo research active scientists who understand the needs and the restraints placed on other cancer researchers or those working in areas peripheral to topoisomerases. Top-selling products include: -Drug Screening Kits to identify topoisomerase active drugs for use in cancer chemotherapy and antibacterial applications -Assay Kits for assaying prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase), both in vitro and in vivo -A complete line of DNA substrates and DNA cleavage targets, topoisomerase inhibitors, topoisomerase antibodies, and kit replenishment reagents Our contract screening service offers you powerful, mechanism based custom screens developed and conducted entirely in house. Our cell based (in vivo) screens for detecting topoisomerase I and II poisons in the context of the cancer cell represents the new gold standard for identification of novel anti cancer agents. Since the early 1990s TopoGEN has maintained a dedicated clientele around the world. We offer substantial product support, data interpretation and consultation advice. When you become our customer, we become your partner in research. We review your data and offer valuable input. Please contact us for further information about how we can assist your research goals.

Contract research organization specializing in solid-state chemistry. The scientists at Triclinic Labs have the proven experience to help you with the most challenging chemical development, solid-form screening and selection, and intellectual property issues. With our expert organic, physical, and analytical chemistry capabilities we can maximize your development and market and franchise potential. Whether you require rapid materials characterization, IP support during patent prosecution or litigation, solid-form development, or chemical troubleshooting assistance with your pharmaceutical or fine chemical, we have the instrumentation and scientific knowledge to help you reach your goals quickly, thoroughly, and cost effectively. We specialize in: - Solid form screening and development - Crystallization Method Development - Amorphous Material Development - Analytical Method Development, Validation, Release testing - cGMP Materials Characterization - Contaminant, Counterfeit, and Product Failure Analysis - Chemical Intellectual Property Support (Patent Prosecution and Litigation)

TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriRx Pharmaceutical Services is a leading global contract development and manufacturing organization (CDMO) that provides comprehensive solutions for the animal health and human pharmaceutical industries. TriRx provides integrated development, manufacturing, and supply services from our network of state-of-the-art facilities across the United States and Europe. Founded by industry veterans, TriRx understands what it means to outsource development and manufacturing of your drug product, and that we are committed to delivering CDMO services at a higher standard of performance. Built on honesty, openness, and integrity, TriRx gives our clients total access to our people and processes, treating your product like its own. TriRx is your partner for advancing products to market. We provide comprehensive development, manufacturing, and packaging capabilities from the clinical- to commercial-scale for both sterile and non-sterile pharmaceutical drug products. Our expertise spans a wide range of services and modalities including: - Biologics - Biotech API - Solid Dose - Drug Development - Analytical Testing - Solutions, Suspensions, and Colloidal Dispersions - Liquids, Creams, Ointments - Fill/Finish - Packaging - Aseptic Compounding - Animal Health Products TriRx maintains strict adherence to the regulatory standards required by the FDA, EMA, and other global health authorities. This, coupled with our rigorous quality control processes, ensures that every product we manufacture meets the highest quality standards. We are more than just a CDMO; we are a trusted partner in the pharmaceutical industry. Whether you are a startup biotech or a multinational pharmaceutical company, TriRx is dedicated to helping you achieve your objectives and bring vital medications to the markets and patients who need them most. Your Product. Your Facility. Your Team. A CDMO You Can Trust.

TriWest Research Associates is a Medical Research Center that conducts high-quality clinical trials to support the biopharmaceutical and scientific research community.

United Biomedical, Inc (UBI) is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. Our product pipeline is filled with our new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, and Allergy, along with a portfolio of animal health diseases. These products are based on our proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies. Our platform technologies are also being used to develop a line of biosimilar versions of widely used protein and antibody drugs whose patents are about to expire. UBI’s proprietary designer peptide technology has been used to produce a line of blood screening diagnostics and the first successfully commercialized synthetic peptide vaccine. Additional revenue streams are generated from pharmaceutical contract manufacturing by our subsidiary UBI-Asia and various sponsorships in product development.

UPM Pharmaceuticals is a Bristol Tennessee based contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology industries. UPM provides high quality pharmaceutical drug development services that include formulation development, cGMP manufacturing and packaging, analytical method development and testing from concept through commercialization. UPM is characterized by its strict sense of quality, timeliness, sound scientific fundamentals, and affordability with which we complete all our projects. We focus on drug development and manufacturing for dosages with oral routes of administration in solid forms such as capsules and tablets, and semi-solid creams and ointments.

US Biolab is a global commercial biobank and human biospecimen CRO providing solutions to biopharmaceutical and academic researchers. We are specializing in contract services for human sample validation studies such as sample collections & histology services. Our expertise is precision medicine and biomedical research projects including biomarker R&D and translational medicine. Our Biobank/repository preserving more than 300,000 high-quality bio-samples, we has developed more than 300 types of tissue microarray and cell microarray products. Sample selection from our bank and customization are both available to build the most satisfactory tissue microarrays. Partnering with us allows you to greatly accelerate and improve your research with guaranteed quality.

VascularStrategies is a CRO providing state-of-the-art in vitro and ex vivo assessment of mediators of cardiovascular and metabolic diseases for drug discovery and development, with cost effective and time saving strategies utilizing proprietary mechanistic assays.  We are a complete resource for functional testing and development of therapeutic candidates for lipid, lipoprotein and metabolic disorders, HDL function, inflammatory markers and CAD. We support programs across the entire drug development spectrum for pharmaceutical, biotech, academic and CRO partners with an extensive repertoire of Biomarkers for Cardiovascular Assessments and Translational Biology.

Vial is a hyper scalable biotech — advancing programs into the clinic powered by dramatically cheaper trials and computationally designed therapeutics.

Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.

Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.

Virtici is an innovation and product development company. We work with a growing ecosystem of world-class scientists, universities, businesses, and investment groups. Together we increase our reach and capital, resulting in enhanced innovation, cost-efficient product development, and more valuable medical products for patients. Virtici is built on the foundation that life changing products are developed through innovation, hard work, and determination. Guided by our core values of innovation, integrity, dedication, teamwork and improvement, the Virtici team focuses on solving life’s biggest health challenges, creating and transforming scientific innovations into life changing medical products. We are always looking for extraordinary people with exceptional creativity and enthusiasm. Every employee contributes to shaping the future of the company. In our fast-paced and entrepreneurial environment, team members are expected to help solve big health-related problems.

WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG's 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy while improving quality outcomes and efficiency through the process. Ninety percent of all clinical trials leverage our knowledge, highly specialized solutions, and data-driven insights to mitigate risk today for a more promising tomorrow.

Westat offers innovative professional services to help clients improve outcomes in health, education, social policy, and transportation. We are dedicated to improving lives through research. Expertise • Data Collection & Management • Clinical Trials • Statistical Research & Survey Methods • Evaluation • Communications & Social Marketing Staff and Locations Westat’s staff of more than 2,000 are located at our headquarters in Rockville, Maryland, near Washington, DC. Additional staff are located at Westat’s data collection survey processing facilities, at our Telephone Research Center facilities, and throughout our nationwide field operations. Westat also maintains research offices near our clients in Atlanta, Georgia; Cambridge, Massachusetts; Raleigh/Durham, North Carolina; Philadelphia, Pennsylvania; Houston, Texas; and San Antonio, Texas. We have international offices in Liberia, Costa Rica; Johannesburg, South Africa; and Bangkok, Thailand. Westat is committed to providing accessible media on LinkedIn. Should you experience difficulties with any posted media, please send us a message at Section508Coordinator@westat.com. An alternative format will be provided upon request.

WuXi Advanced Therapies - Accelerating Progress and Time to Market WuXi Advanced Therapies is a cell and gene therapy Contract Testing, Development and Manufacturing Organization (CTDMO) that is reducing the complexities of manufacturing by providing integrated platforms that enable cell and gene therapies to be developed, manufactured, and released faster and with greater predictability. Our Story By leveraging platforms and integrated testing our team provides expedited development and commercialization of cell, gene, protein and viral-based therapies. This approach enables new biopharmaceuticals to be developed, manufactured and released faster and with greater predictability, thereby reducing the complexities of high-touch, multi-vendor production models. Our solutions help clients overcome challenges to commercialization, including process development, manufacturing capacity, analytical development, and raw materials management. Multiple, scale-able, enabling platforms integrate manufacturing, process development and testing capabilities to provide greater predictability and speed to clinic. We support advanced therapy programs with extensive infrastructure and 400,000+ square feet of state-of-the-art, GMP-compliant facilities on our modern campus located at the Navy Yard in Philadelphia, Pennsylvania.

The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.

Mixed Lymphocyte Reactions are cell proliferation assays. We offer a comprehensive selection of MLRs experiments to test your product.

We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the best capabilities and resources available to us in each market to meet the needs of our customers and collaborators. Beyond our team’s domain expertise and creative thinking, the key to our mission is the integrated technology platform, which combines the mutually informing and reinforcing cloud supercomputing-powered in silico tools and our wet lab with robotic automation, and enables discovery and development of innovative therapeutics at a pace and scale beyond traditional alternatives. We are among the pioneering AI-powered drug R&D companies in the world that have established a platform with an iterative feedback loop between quantum physics-based dry lab and wet lab capabilities, according to Frost & Sullivan. With our platform designed to improve dry lab calculations with experimental data generated by the wet lab and enhance the efficiency of the wet lab by insights derived from dry lab calculations, we believe that we are well positioned at this moment where the combination of AI, computing power, data and automation is becoming increasingly critical for pharmaceutical development. Since our founding, we have received investments and support from world-renowned investors, and we believe this blue-chip shareholder base is a testament to our capabilities and prospects.

Yurogen Biosystems LLC is a private biotech company based in the Greater Boston area, a world-class biotech and biopharma hub. We are dedicated to produce premium antibodies and antibody-based products to meet broad needs of our clients. Along with our traditional polyclonal antibody production, Yurogen is commercializing an innovative platform that can efficiently develop monoclonal antibodies from a variety of host animals especially rabbit. Yurogen is developing a selection of antibodies that are widely used in in vitro diagnostics (IVD) as well as academic research. Our growing list of high quality antibodies are the reliable and cost-efficient tools that you can count on. Customized antibody services is offered at Yurogen to generate antibodies to meet the needs of our clients. Our state-of-the-art monoclonal antibody screening platform can significantly shorten the antibody screening process and yield high affinity monoclonal antibodies.

At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our platform. As such, we seek to ensure that DEI is in our DNA, continuing to grow an inclusive culture and diverse workforce. Let's make biology easier to engineer and join our team.